PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Snai1
|
ENSMUSG00000042821.8 | Snai1 |
Zeb1
|
ENSMUSG00000024238.16 | Zeb1 |
Snai2
|
ENSMUSG00000022676.8 | Snai2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Zeb1 | mm39_v1_chr18_+_5591864_5591902 | -0.39 | 6.1e-04 | Click! |
Snai2 | mm39_v1_chr16_+_14523696_14523722 | -0.16 | 1.7e-01 | Click! |
Snai1 | mm39_v1_chr2_+_167380112_167380130 | -0.06 | 6.4e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr11_+_69856222 | 96.33 |
ENSMUST00000018713.13
|
Cldn7
|
claudin 7 |
chr9_-_21223551 | 77.39 |
ENSMUST00000003397.9
ENSMUST00000213250.2 |
Ap1m2
|
adaptor protein complex AP-1, mu 2 subunit |
chr17_+_57369231 | 72.09 |
ENSMUST00000097299.10
ENSMUST00000169543.8 ENSMUST00000163763.2 |
Crb3
|
crumbs family member 3 |
chr12_-_73593157 | 69.89 |
ENSMUST00000042975.7
|
Tmem30b
|
transmembrane protein 30B |
chr4_-_116024788 | 67.49 |
ENSMUST00000030465.10
ENSMUST00000143426.2 |
Tspan1
|
tetraspanin 1 |
chr9_-_21223631 | 64.90 |
ENSMUST00000115433.11
|
Ap1m2
|
adaptor protein complex AP-1, mu 2 subunit |
chr7_-_28981335 | 64.23 |
ENSMUST00000108236.5
ENSMUST00000098604.12 |
Spint2
|
serine protease inhibitor, Kunitz type 2 |
chr8_+_107329983 | 63.88 |
ENSMUST00000000312.12
ENSMUST00000167688.2 |
Cdh1
|
cadherin 1 |
chr1_+_74448535 | 57.64 |
ENSMUST00000027366.13
|
Vil1
|
villin 1 |
chr4_+_133246274 | 56.81 |
ENSMUST00000149807.2
ENSMUST00000042919.16 ENSMUST00000153811.2 ENSMUST00000105901.2 ENSMUST00000121797.2 |
Kdf1
|
keratinocyte differentiation factor 1 |
chr4_-_11386756 | 55.32 |
ENSMUST00000108313.8
ENSMUST00000108311.9 |
Esrp1
|
epithelial splicing regulatory protein 1 |
chr4_-_154384464 | 52.70 |
ENSMUST00000030898.12
|
Arhgef16
|
Rho guanine nucleotide exchange factor (GEF) 16 |
chr13_-_100688949 | 51.18 |
ENSMUST00000159515.2
ENSMUST00000160859.8 ENSMUST00000069756.11 |
Ocln
|
occludin |
chr4_-_11386679 | 50.91 |
ENSMUST00000043781.14
ENSMUST00000108310.8 |
Esrp1
|
epithelial splicing regulatory protein 1 |
chr2_+_167922924 | 49.66 |
ENSMUST00000052125.7
|
Pard6b
|
par-6 family cell polarity regulator beta |
chr4_+_106479624 | 49.11 |
ENSMUST00000047922.3
|
Ttc22
|
tetratricopeptide repeat domain 22 |
chr1_+_78286946 | 48.67 |
ENSMUST00000036172.10
|
Sgpp2
|
sphingosine-1-phosphate phosphatase 2 |
chr2_-_65955338 | 48.42 |
ENSMUST00000028378.4
|
Galnt3
|
polypeptide N-acetylgalactosaminyltransferase 3 |
chr4_-_154384305 | 48.41 |
ENSMUST00000154895.2
|
Arhgef16
|
Rho guanine nucleotide exchange factor (GEF) 16 |
chr15_-_75881289 | 48.14 |
ENSMUST00000170153.2
|
Fam83h
|
family with sequence similarity 83, member H |
chr17_+_28988354 | 48.02 |
ENSMUST00000233109.2
ENSMUST00000004986.14 |
Mapk13
|
mitogen-activated protein kinase 13 |
chr11_+_115714853 | 46.69 |
ENSMUST00000103032.11
ENSMUST00000133250.8 ENSMUST00000177736.8 |
Llgl2
|
LLGL2 scribble cell polarity complex component |
chr17_+_23879448 | 45.96 |
ENSMUST00000062967.10
|
Bicdl2
|
BICD family like cargo adaptor 2 |
chr17_+_28988271 | 43.61 |
ENSMUST00000233984.2
ENSMUST00000233460.2 |
Mapk13
|
mitogen-activated protein kinase 13 |
chr11_+_96820220 | 42.24 |
ENSMUST00000062172.6
|
Prr15l
|
proline rich 15-like |
chr4_+_43506966 | 41.74 |
ENSMUST00000030183.10
|
Car9
|
carbonic anhydrase 9 |
chr11_+_96820091 | 41.73 |
ENSMUST00000054311.6
ENSMUST00000107636.4 |
Prr15l
|
proline rich 15-like |
chr13_-_100689212 | 41.67 |
ENSMUST00000022140.12
|
Ocln
|
occludin |
chr13_-_100689105 | 41.46 |
ENSMUST00000159459.8
|
Ocln
|
occludin |
chr4_+_118384426 | 41.29 |
ENSMUST00000030261.6
|
2610528J11Rik
|
RIKEN cDNA 2610528J11 gene |
chr5_-_139799953 | 40.86 |
ENSMUST00000044002.10
|
Tmem184a
|
transmembrane protein 184a |
chr2_+_122479770 | 40.79 |
ENSMUST00000047498.15
ENSMUST00000110512.4 |
AA467197
|
expressed sequence AA467197 |
chr3_-_92393193 | 39.34 |
ENSMUST00000054599.8
|
Sprr1a
|
small proline-rich protein 1A |
chr7_-_30672824 | 39.33 |
ENSMUST00000147431.2
ENSMUST00000098553.11 ENSMUST00000108116.10 |
Lsr
|
lipolysis stimulated lipoprotein receptor |
chr10_+_79656823 | 38.70 |
ENSMUST00000169041.9
|
Misp
|
mitotic spindle positioning |
chr1_+_118555668 | 38.27 |
ENSMUST00000027629.10
|
Tfcp2l1
|
transcription factor CP2-like 1 |
chr11_-_100036792 | 38.23 |
ENSMUST00000007317.8
|
Krt19
|
keratin 19 |
chr12_-_76842263 | 38.01 |
ENSMUST00000082431.6
|
Gpx2
|
glutathione peroxidase 2 |
chr8_-_110688716 | 37.76 |
ENSMUST00000001722.14
ENSMUST00000051430.7 |
Marveld3
|
MARVEL (membrane-associating) domain containing 3 |
chr1_+_192835414 | 37.72 |
ENSMUST00000076521.7
|
Irf6
|
interferon regulatory factor 6 |
chr15_-_97806142 | 37.67 |
ENSMUST00000023119.15
|
Vdr
|
vitamin D (1,25-dihydroxyvitamin D3) receptor |
chr11_-_120954281 | 36.59 |
ENSMUST00000130786.2
ENSMUST00000168459.8 ENSMUST00000081499.9 ENSMUST00000039309.12 |
Sectm1b
|
secreted and transmembrane 1B |
chr3_-_88455556 | 36.46 |
ENSMUST00000131775.2
ENSMUST00000008745.13 |
Rab25
|
RAB25, member RAS oncogene family |
chr3_-_151871867 | 36.23 |
ENSMUST00000046614.10
|
Gipc2
|
GIPC PDZ domain containing family, member 2 |
chr15_+_54434576 | 35.94 |
ENSMUST00000025356.4
|
Mal2
|
mal, T cell differentiation protein 2 |
chr7_-_30776081 | 35.89 |
ENSMUST00000072331.13
ENSMUST00000167369.8 |
Fxyd3
|
FXYD domain-containing ion transport regulator 3 |
chr9_-_76474374 | 35.81 |
ENSMUST00000183437.8
|
Fam83b
|
family with sequence similarity 83, member B |
chr1_+_135746330 | 35.59 |
ENSMUST00000038760.10
|
Lad1
|
ladinin |
chr8_+_3637785 | 35.56 |
ENSMUST00000171962.3
ENSMUST00000207712.2 ENSMUST00000207970.2 ENSMUST00000207533.2 ENSMUST00000208240.2 ENSMUST00000207432.2 ENSMUST00000207077.2 |
Camsap3
|
calmodulin regulated spectrin-associated protein family, member 3 |
chr2_+_119068012 | 35.31 |
ENSMUST00000110817.3
|
Spint1
|
serine protease inhibitor, Kunitz type 1 |
chr17_+_57369490 | 34.68 |
ENSMUST00000163628.2
|
Crb3
|
crumbs family member 3 |
chr2_+_119067832 | 33.88 |
ENSMUST00000028783.14
|
Spint1
|
serine protease inhibitor, Kunitz type 1 |
chr7_+_140918793 | 33.85 |
ENSMUST00000026577.13
|
Eps8l2
|
EPS8-like 2 |
chr18_+_74575567 | 33.54 |
ENSMUST00000074157.13
|
Myo5b
|
myosin VB |
chr11_+_69855584 | 33.35 |
ENSMUST00000108597.8
ENSMUST00000060651.6 ENSMUST00000108596.8 |
Cldn7
|
claudin 7 |
chr2_+_119067929 | 33.23 |
ENSMUST00000110816.8
|
Spint1
|
serine protease inhibitor, Kunitz type 1 |
chr18_+_74575623 | 33.01 |
ENSMUST00000121875.8
|
Myo5b
|
myosin VB |
chr17_-_73706284 | 33.00 |
ENSMUST00000095208.4
|
Capn13
|
calpain 13 |
chr16_+_36514334 | 32.64 |
ENSMUST00000023617.13
ENSMUST00000089618.10 |
Ildr1
|
immunoglobulin-like domain containing receptor 1 |
chr1_-_153061758 | 32.60 |
ENSMUST00000185356.7
|
Lamc2
|
laminin, gamma 2 |
chr7_-_30672889 | 32.18 |
ENSMUST00000001279.15
|
Lsr
|
lipolysis stimulated lipoprotein receptor |
chr15_+_37233280 | 31.96 |
ENSMUST00000161405.8
ENSMUST00000022895.15 ENSMUST00000161532.2 |
Grhl2
|
grainyhead like transcription factor 2 |
chr16_-_97412169 | 31.89 |
ENSMUST00000232141.2
ENSMUST00000000395.8 |
Tmprss2
|
transmembrane protease, serine 2 |
chr9_-_95727267 | 31.79 |
ENSMUST00000093800.9
|
Pls1
|
plastin 1 (I-isoform) |
chr18_+_20691095 | 31.78 |
ENSMUST00000059787.15
ENSMUST00000120102.8 |
Dsg2
|
desmoglein 2 |
chr17_+_87943401 | 31.46 |
ENSMUST00000235125.2
ENSMUST00000053577.9 ENSMUST00000234009.2 |
Epcam
|
epithelial cell adhesion molecule |
chr1_-_64776890 | 31.39 |
ENSMUST00000116133.4
ENSMUST00000063982.7 |
Fzd5
|
frizzled class receptor 5 |
chr5_-_93192881 | 31.30 |
ENSMUST00000061328.6
|
Sowahb
|
sosondowah ankyrin repeat domain family member B |
chr4_-_11386394 | 31.23 |
ENSMUST00000155519.2
|
Esrp1
|
epithelial splicing regulatory protein 1 |
chr5_-_144294854 | 31.22 |
ENSMUST00000055190.8
|
Baiap2l1
|
BAI1-associated protein 2-like 1 |
chr4_-_130169335 | 31.02 |
ENSMUST00000154846.2
ENSMUST00000105996.8 |
Serinc2
|
serine incorporator 2 |
chr7_-_30672747 | 30.99 |
ENSMUST00000205961.2
|
Lsr
|
lipolysis stimulated lipoprotein receptor |
chr3_+_106389732 | 30.68 |
ENSMUST00000029508.11
|
Dennd2d
|
DENN/MADD domain containing 2D |
chr16_-_97564910 | 30.43 |
ENSMUST00000019386.10
|
Ripk4
|
receptor-interacting serine-threonine kinase 4 |
chr12_-_101684772 | 30.42 |
ENSMUST00000162735.8
|
Tc2n
|
tandem C2 domains, nuclear |
chr5_-_53370761 | 30.13 |
ENSMUST00000031090.8
|
Sel1l3
|
sel-1 suppressor of lin-12-like 3 (C. elegans) |
chr7_+_140795765 | 30.12 |
ENSMUST00000046890.12
ENSMUST00000209500.2 |
Rassf7
|
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7 |
chrX_+_100427331 | 30.06 |
ENSMUST00000119190.2
|
Gjb1
|
gap junction protein, beta 1 |
chr4_+_118384183 | 29.81 |
ENSMUST00000106367.8
|
2610528J11Rik
|
RIKEN cDNA 2610528J11 gene |
chr7_+_140659672 | 29.63 |
ENSMUST00000066873.5
ENSMUST00000163041.2 |
Pkp3
|
plakophilin 3 |
chr14_+_47611270 | 29.01 |
ENSMUST00000142734.8
ENSMUST00000150290.9 ENSMUST00000226585.2 ENSMUST00000144794.2 ENSMUST00000146468.4 |
Lgals3
|
lectin, galactose binding, soluble 3 |
chr1_+_40619215 | 28.90 |
ENSMUST00000027233.9
|
Slc9a4
|
solute carrier family 9 (sodium/hydrogen exchanger), member 4 |
chr7_-_4792530 | 28.78 |
ENSMUST00000168578.3
|
Tmem238
|
transmembrane protein 238 |
chr3_-_108443769 | 28.48 |
ENSMUST00000048012.13
ENSMUST00000106625.10 |
Elapor1
|
endosome-lysosome associated apoptosis and autophagy regulator 1 |
chr16_-_97306125 | 28.47 |
ENSMUST00000049721.9
ENSMUST00000231999.2 |
Fam3b
|
family with sequence similarity 3, member B |
chr4_-_130169006 | 28.38 |
ENSMUST00000122374.8
|
Serinc2
|
serine incorporator 2 |
chr15_-_101912917 | 28.35 |
ENSMUST00000023952.10
|
Krt8
|
keratin 8 |
chr2_+_118603247 | 28.10 |
ENSMUST00000061360.4
ENSMUST00000130293.8 |
Phgr1
|
proline/histidine/glycine-rich 1 |
chr10_+_88721854 | 28.00 |
ENSMUST00000020255.8
|
Slc5a8
|
solute carrier family 5 (iodide transporter), member 8 |
chr6_+_125298372 | 27.93 |
ENSMUST00000176442.8
ENSMUST00000177329.2 |
Scnn1a
|
sodium channel, nonvoltage-gated 1 alpha |
chr14_+_101967343 | 27.84 |
ENSMUST00000100337.10
|
Lmo7
|
LIM domain only 7 |
chr11_-_67812960 | 27.74 |
ENSMUST00000021288.10
ENSMUST00000108677.2 |
Usp43
|
ubiquitin specific peptidase 43 |
chr15_+_80556023 | 27.70 |
ENSMUST00000023044.7
|
Fam83f
|
family with sequence similarity 83, member F |
chr17_+_47747657 | 27.58 |
ENSMUST00000150819.3
|
AI661453
|
expressed sequence AI661453 |
chr16_-_88360037 | 27.42 |
ENSMUST00000049697.5
|
Cldn8
|
claudin 8 |
chr5_+_53206688 | 27.33 |
ENSMUST00000094787.8
|
Slc34a2
|
solute carrier family 34 (sodium phosphate), member 2 |
chr13_-_32522548 | 27.19 |
ENSMUST00000041859.9
|
Gmds
|
GDP-mannose 4, 6-dehydratase |
chr7_+_18618605 | 27.16 |
ENSMUST00000032573.8
|
Pglyrp1
|
peptidoglycan recognition protein 1 |
chr7_+_27770655 | 27.08 |
ENSMUST00000138392.8
ENSMUST00000076648.8 |
Fcgbp
|
Fc fragment of IgG binding protein |
chr12_+_36042899 | 26.96 |
ENSMUST00000020898.12
|
Agr2
|
anterior gradient 2 |
chr11_-_80670815 | 26.89 |
ENSMUST00000041065.14
ENSMUST00000070997.6 |
Myo1d
|
myosin ID |
chr18_+_20691278 | 26.83 |
ENSMUST00000121837.2
|
Dsg2
|
desmoglein 2 |
chr3_+_90434160 | 26.65 |
ENSMUST00000199538.5
ENSMUST00000164481.7 ENSMUST00000167598.6 |
S100a14
|
S100 calcium binding protein A14 |
chr13_+_108350923 | 26.35 |
ENSMUST00000022207.10
|
Elovl7
|
ELOVL family member 7, elongation of long chain fatty acids (yeast) |
chr7_+_140795866 | 26.23 |
ENSMUST00000210993.2
ENSMUST00000133763.8 |
Rassf7
|
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7 |
chr18_-_64794338 | 26.13 |
ENSMUST00000025482.10
|
Atp8b1
|
ATPase, class I, type 8B, member 1 |
chr6_-_87327885 | 26.05 |
ENSMUST00000032129.3
|
Gkn1
|
gastrokine 1 |
chr2_+_143757193 | 26.00 |
ENSMUST00000103172.4
|
Dstn
|
destrin |
chr5_-_90788323 | 25.76 |
ENSMUST00000202784.4
ENSMUST00000031317.10 ENSMUST00000201370.2 |
Rassf6
|
Ras association (RalGDS/AF-6) domain family member 6 |
chr6_-_125357756 | 25.74 |
ENSMUST00000042647.7
|
Plekhg6
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 6 |
chr19_-_11796282 | 25.47 |
ENSMUST00000069285.6
|
Stx3
|
syntaxin 3 |
chr3_+_89136353 | 25.23 |
ENSMUST00000041142.4
|
Muc1
|
mucin 1, transmembrane |
chr10_+_79658392 | 25.22 |
ENSMUST00000219305.2
ENSMUST00000046833.5 ENSMUST00000218687.2 |
Misp
|
mitotic spindle positioning |
chr8_-_112120442 | 25.18 |
ENSMUST00000038475.9
|
Fa2h
|
fatty acid 2-hydroxylase |
chr10_+_75399920 | 25.15 |
ENSMUST00000141062.8
ENSMUST00000152657.8 |
Ggt1
|
gamma-glutamyltransferase 1 |
chr7_-_19530714 | 24.85 |
ENSMUST00000108449.9
ENSMUST00000043822.8 |
Cblc
|
Casitas B-lineage lymphoma c |
chr6_+_54303837 | 24.57 |
ENSMUST00000059138.6
|
Prr15
|
proline rich 15 |
chr5_+_91287448 | 24.49 |
ENSMUST00000031325.6
|
Areg
|
amphiregulin |
chr5_-_90788460 | 24.37 |
ENSMUST00000202704.4
|
Rassf6
|
Ras association (RalGDS/AF-6) domain family member 6 |
chr6_-_120271520 | 24.35 |
ENSMUST00000057283.8
ENSMUST00000212457.2 |
B4galnt3
|
beta-1,4-N-acetyl-galactosaminyl transferase 3 |
chr2_-_92201342 | 24.29 |
ENSMUST00000176810.8
ENSMUST00000090582.11 ENSMUST00000068586.13 |
Large2
|
LARGE xylosyl- and glucuronyltransferase 2 |
chr16_+_36514386 | 24.26 |
ENSMUST00000119464.2
|
Ildr1
|
immunoglobulin-like domain containing receptor 1 |
chr6_+_125298296 | 24.02 |
ENSMUST00000081440.14
|
Scnn1a
|
sodium channel, nonvoltage-gated 1 alpha |
chr5_-_66308421 | 23.89 |
ENSMUST00000200775.4
ENSMUST00000094756.11 |
Rbm47
|
RNA binding motif protein 47 |
chr4_-_130169316 | 23.89 |
ENSMUST00000146478.8
|
Serinc2
|
serine incorporator 2 |
chr6_+_43242516 | 23.72 |
ENSMUST00000031750.14
|
Arhgef5
|
Rho guanine nucleotide exchange factor (GEF) 5 |
chr12_+_30961650 | 23.68 |
ENSMUST00000020997.15
ENSMUST00000110880.3 |
Sh3yl1
|
Sh3 domain YSC-like 1 |
chrX_+_100420873 | 23.61 |
ENSMUST00000052130.14
|
Gjb1
|
gap junction protein, beta 1 |
chr10_+_43455157 | 23.61 |
ENSMUST00000058714.10
|
Cd24a
|
CD24a antigen |
chr16_-_23709564 | 23.59 |
ENSMUST00000004480.5
|
Sst
|
somatostatin |
chr13_-_95661726 | 23.41 |
ENSMUST00000022185.10
|
F2rl1
|
coagulation factor II (thrombin) receptor-like 1 |
chr8_+_85717210 | 23.27 |
ENSMUST00000209764.2
ENSMUST00000064495.8 ENSMUST00000210326.2 |
Hook2
|
hook microtubule tethering protein 2 |
chr11_+_68447012 | 23.17 |
ENSMUST00000053211.8
|
Mfsd6l
|
major facilitator superfamily domain containing 6-like |
chr7_+_45370607 | 22.87 |
ENSMUST00000129507.5
|
Fam83e
|
family with sequence similarity 83, member E |
chr6_+_42238891 | 22.86 |
ENSMUST00000095987.4
|
Tmem139
|
transmembrane protein 139 |
chr4_+_133207437 | 22.79 |
ENSMUST00000051676.7
|
Tent5b
|
terminal nucleotidyltransferase 5B |
chr15_+_101310283 | 22.79 |
ENSMUST00000068904.9
|
Krt7
|
keratin 7 |
chr7_-_115907476 | 22.62 |
ENSMUST00000183057.2
ENSMUST00000216517.2 ENSMUST00000182487.8 ENSMUST00000181998.8 |
Plekha7
|
pleckstrin homology domain containing, family A member 7 |
chr7_-_4607040 | 22.36 |
ENSMUST00000166650.3
|
Ptprh
|
protein tyrosine phosphatase, receptor type, H |
chr3_+_107784543 | 22.30 |
ENSMUST00000037375.10
ENSMUST00000199990.2 |
Eps8l3
|
EPS8-like 3 |
chr13_-_63006176 | 22.22 |
ENSMUST00000021907.9
|
Fbp2
|
fructose bisphosphatase 2 |
chr7_+_30673212 | 22.16 |
ENSMUST00000129773.2
|
Fam187b
|
family with sequence similarity 187, member B |
chr11_+_61575245 | 22.03 |
ENSMUST00000093019.6
|
Fam83g
|
family with sequence similarity 83, member G |
chr11_-_115258508 | 22.03 |
ENSMUST00000044152.13
ENSMUST00000106542.9 |
Hid1
|
HID1 domain containing |
chr5_-_139799780 | 21.87 |
ENSMUST00000146780.3
|
Tmem184a
|
transmembrane protein 184a |
chr9_-_31375497 | 21.87 |
ENSMUST00000217007.2
ENSMUST00000213807.2 |
Tmem45b
|
transmembrane protein 45b |
chr10_-_44024843 | 21.75 |
ENSMUST00000200401.2
|
Crybg1
|
crystallin beta-gamma domain containing 1 |
chr17_+_37253802 | 21.58 |
ENSMUST00000040498.12
|
Rnf39
|
ring finger protein 39 |
chr10_-_128237087 | 21.41 |
ENSMUST00000042666.13
|
Slc39a5
|
solute carrier family 39 (metal ion transporter), member 5 |
chr3_+_10431961 | 21.33 |
ENSMUST00000029049.7
|
Chmp4c
|
charged multivesicular body protein 4C |
chr4_-_133329479 | 21.18 |
ENSMUST00000057311.4
|
Sfn
|
stratifin |
chr3_-_121325887 | 21.07 |
ENSMUST00000039197.9
|
Slc44a3
|
solute carrier family 44, member 3 |
chr5_+_101912939 | 21.02 |
ENSMUST00000031273.9
|
Cds1
|
CDP-diacylglycerol synthase 1 |
chr7_+_141342696 | 20.90 |
ENSMUST00000155534.9
ENSMUST00000041924.14 ENSMUST00000163321.3 |
Muc5ac
|
mucin 5, subtypes A and C, tracheobronchial/gastric |
chr7_+_140796096 | 20.88 |
ENSMUST00000153081.2
|
Rassf7
|
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7 |
chr4_+_85123654 | 20.67 |
ENSMUST00000030212.15
ENSMUST00000107189.8 ENSMUST00000107184.8 |
Sh3gl2
|
SH3-domain GRB2-like 2 |
chr13_-_58758691 | 20.67 |
ENSMUST00000022036.14
|
Slc28a3
|
solute carrier family 28 (sodium-coupled nucleoside transporter), member 3 |
chr8_-_27664651 | 20.58 |
ENSMUST00000054212.7
ENSMUST00000033878.14 ENSMUST00000209377.2 |
Rab11fip1
|
RAB11 family interacting protein 1 (class I) |
chr11_-_69749549 | 20.56 |
ENSMUST00000001626.10
ENSMUST00000108626.8 |
Tnk1
|
tyrosine kinase, non-receptor, 1 |
chr9_-_123045087 | 20.55 |
ENSMUST00000039229.8
|
Cdcp1
|
CUB domain containing protein 1 |
chr7_-_126651847 | 20.50 |
ENSMUST00000205424.2
|
Zg16
|
zymogen granule protein 16 |
chr8_-_106863423 | 20.40 |
ENSMUST00000146940.2
|
Esrp2
|
epithelial splicing regulatory protein 2 |
chr9_-_31043076 | 20.40 |
ENSMUST00000034478.3
|
St14
|
suppression of tumorigenicity 14 (colon carcinoma) |
chr11_+_81948649 | 20.40 |
ENSMUST00000000342.3
|
Ccl11
|
chemokine (C-C motif) ligand 11 |
chr2_+_25132941 | 20.37 |
ENSMUST00000114355.2
ENSMUST00000060818.2 |
Rnf208
|
ring finger protein 208 |
chr3_-_89300936 | 20.31 |
ENSMUST00000124783.8
ENSMUST00000126027.8 |
Zbtb7b
|
zinc finger and BTB domain containing 7B |
chr6_+_125298168 | 20.21 |
ENSMUST00000176365.2
|
Scnn1a
|
sodium channel, nonvoltage-gated 1 alpha |
chr15_+_101936615 | 20.20 |
ENSMUST00000023803.8
|
Krt18
|
keratin 18 |
chr1_-_135186176 | 20.15 |
ENSMUST00000185752.2
ENSMUST00000003135.14 |
Elf3
|
E74-like factor 3 |
chr7_+_140918876 | 20.12 |
ENSMUST00000143633.4
|
Eps8l2
|
EPS8-like 2 |
chr19_-_5399368 | 20.10 |
ENSMUST00000238111.2
|
Cst6
|
cystatin E/M |
chr4_-_129142208 | 20.06 |
ENSMUST00000052602.6
|
C77080
|
expressed sequence C77080 |
chr1_+_130754413 | 20.04 |
ENSMUST00000027675.14
ENSMUST00000133792.8 |
Pigr
|
polymeric immunoglobulin receptor |
chr10_-_61946724 | 19.98 |
ENSMUST00000142821.8
ENSMUST00000124615.8 ENSMUST00000064050.5 ENSMUST00000125704.8 ENSMUST00000142796.8 |
Fam241b
|
family with sequence similarity 241, member B |
chr19_+_6356486 | 19.91 |
ENSMUST00000025681.8
|
Cdc42bpg
|
CDC42 binding protein kinase gamma (DMPK-like) |
chr3_-_107129038 | 19.88 |
ENSMUST00000029504.9
|
Cym
|
chymosin |
chr11_+_115865535 | 19.86 |
ENSMUST00000021107.14
ENSMUST00000169928.8 ENSMUST00000106461.8 |
Itgb4
|
integrin beta 4 |
chr10_-_81127057 | 19.85 |
ENSMUST00000045744.7
|
Tjp3
|
tight junction protein 3 |
chr18_+_36481706 | 19.80 |
ENSMUST00000235864.2
ENSMUST00000050584.10 |
Cystm1
|
cysteine-rich transmembrane module containing 1 |
chr9_+_53212871 | 19.69 |
ENSMUST00000051014.2
|
Exph5
|
exophilin 5 |
chr4_-_132990362 | 19.66 |
ENSMUST00000105908.10
ENSMUST00000030674.8 |
Sytl1
|
synaptotagmin-like 1 |
chr8_+_120426748 | 19.62 |
ENSMUST00000095171.5
ENSMUST00000212454.2 |
Atp2c2
|
ATPase, Ca++ transporting, type 2C, member 2 |
chr3_-_94693740 | 19.57 |
ENSMUST00000153263.9
ENSMUST00000107272.7 ENSMUST00000155485.4 |
Cgn
|
cingulin |
chr5_+_31409021 | 19.46 |
ENSMUST00000054829.13
ENSMUST00000201625.4 ENSMUST00000201937.4 |
Krtcap3
|
keratinocyte associated protein 3 |
chr2_-_119060366 | 19.42 |
ENSMUST00000076084.6
|
Ppp1r14d
|
protein phosphatase 1, regulatory inhibitor subunit 14D |
chr17_-_35954573 | 19.37 |
ENSMUST00000095467.4
|
Mucl3
|
mucin like 3 |
chr10_+_98943999 | 19.35 |
ENSMUST00000161240.4
|
Galnt4
|
polypeptide N-acetylgalactosaminyltransferase 4 |
chr10_+_108168520 | 19.35 |
ENSMUST00000218332.2
|
Pawr
|
PRKC, apoptosis, WT1, regulator |
chr3_-_132940647 | 19.28 |
ENSMUST00000147041.10
ENSMUST00000161022.9 |
Arhgef38
|
Rho guanine nucleotide exchange factor (GEF) 38 |
chr12_+_85520652 | 19.27 |
ENSMUST00000021674.7
|
Fos
|
FBJ osteosarcoma oncogene |
chr7_+_19699291 | 19.23 |
ENSMUST00000094753.6
|
Ceacam20
|
carcinoembryonic antigen-related cell adhesion molecule 20 |
chr4_-_141327146 | 19.21 |
ENSMUST00000141518.8
ENSMUST00000127455.8 ENSMUST00000105784.8 |
Fblim1
|
filamin binding LIM protein 1 |
chr7_-_140859034 | 19.10 |
ENSMUST00000211667.2
ENSMUST00000167790.3 ENSMUST00000046156.13 |
Sct
|
secretin |
chr17_+_47747540 | 19.06 |
ENSMUST00000037701.13
|
AI661453
|
expressed sequence AI661453 |
chr1_+_171265103 | 19.03 |
ENSMUST00000043839.5
|
F11r
|
F11 receptor |
chr7_-_79882501 | 18.88 |
ENSMUST00000065163.15
|
Cib1
|
calcium and integrin binding 1 (calmyrin) |
chr18_+_36481792 | 18.83 |
ENSMUST00000152804.9
|
Cystm1
|
cysteine-rich transmembrane module containing 1 |
chr3_-_94693780 | 18.81 |
ENSMUST00000107273.9
ENSMUST00000238849.2 |
Cgn
|
cingulin |
chr7_-_28947882 | 18.78 |
ENSMUST00000032808.6
|
2200002D01Rik
|
RIKEN cDNA 2200002D01 gene |
chr12_-_78953703 | 18.73 |
ENSMUST00000021544.8
|
Plek2
|
pleckstrin 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
38.9 | 116.6 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
34.2 | 102.5 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
26.5 | 79.6 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
25.7 | 102.7 | GO:1902896 | terminal web assembly(GO:1902896) |
18.4 | 55.1 | GO:0003165 | Purkinje myocyte development(GO:0003165) |
15.3 | 15.3 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
13.9 | 55.7 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
13.3 | 80.0 | GO:0018992 | germ-line sex determination(GO:0018992) |
12.9 | 77.3 | GO:0002159 | desmosome assembly(GO:0002159) |
12.2 | 48.6 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
12.1 | 36.2 | GO:0060450 | positive regulation of hindgut contraction(GO:0060450) |
12.0 | 71.8 | GO:0032439 | endosome localization(GO:0032439) |
12.0 | 47.8 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
11.8 | 82.9 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
11.2 | 33.5 | GO:0051977 | lysophospholipid transport(GO:0051977) |
11.0 | 66.1 | GO:0060066 | oviduct development(GO:0060066) |
11.0 | 121.0 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
10.9 | 76.4 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
10.5 | 31.4 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
10.2 | 40.8 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
10.1 | 50.3 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
10.1 | 30.2 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) positive regulation of cytolysis in other organism(GO:0051714) |
9.4 | 37.8 | GO:0009609 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
9.4 | 28.2 | GO:1903896 | positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
9.2 | 64.6 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
8.8 | 26.4 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
8.3 | 25.0 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
8.1 | 145.9 | GO:0070673 | response to interleukin-18(GO:0070673) |
8.1 | 48.4 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
8.0 | 24.1 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
7.8 | 23.4 | GO:0034118 | erythrocyte aggregation(GO:0034117) regulation of erythrocyte aggregation(GO:0034118) |
7.8 | 23.4 | GO:1900135 | positive regulation of renin secretion into blood stream(GO:1900135) |
7.7 | 23.2 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
7.7 | 23.0 | GO:0048627 | myoblast development(GO:0048627) |
7.5 | 15.1 | GO:0060197 | cloacal septation(GO:0060197) |
7.3 | 22.0 | GO:0033624 | negative regulation of integrin activation(GO:0033624) |
7.3 | 29.0 | GO:2001189 | negative regulation of immunological synapse formation(GO:2000521) regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001188) negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001189) |
7.1 | 21.3 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
7.1 | 28.3 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
7.1 | 106.0 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
6.9 | 20.8 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
6.9 | 20.7 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) nucleoside transmembrane transport(GO:1901642) |
6.9 | 55.0 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
6.8 | 33.9 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
6.8 | 67.6 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
6.6 | 26.5 | GO:0060598 | dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
6.4 | 141.5 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
6.4 | 19.2 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
6.3 | 6.3 | GO:0099545 | trans-synaptic signaling by trans-synaptic complex(GO:0099545) |
6.2 | 81.2 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
6.2 | 99.1 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
5.9 | 17.7 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
5.7 | 23.0 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
5.7 | 11.3 | GO:0060003 | copper ion export(GO:0060003) |
5.7 | 5.7 | GO:0070237 | positive regulation of activation-induced cell death of T cells(GO:0070237) |
5.5 | 22.0 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
5.5 | 225.0 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
5.4 | 32.6 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
5.4 | 32.6 | GO:1903609 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
5.4 | 32.6 | GO:0030043 | actin filament fragmentation(GO:0030043) |
5.4 | 32.5 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
5.4 | 16.1 | GO:0061076 | negative regulation of neural retina development(GO:0061076) negative regulation of retina development in camera-type eye(GO:1902867) negative regulation of amacrine cell differentiation(GO:1902870) |
5.3 | 58.5 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
5.3 | 26.3 | GO:1904349 | positive regulation of small intestine smooth muscle contraction(GO:1904349) |
5.1 | 10.3 | GO:1903921 | protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
5.0 | 15.1 | GO:1902569 | regulation of activation of JAK2 kinase activity(GO:0010534) activation of JAK2 kinase activity(GO:0042977) negative regulation of activation of JAK2 kinase activity(GO:1902569) |
5.0 | 15.0 | GO:0072347 | response to anesthetic(GO:0072347) |
4.9 | 14.8 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
4.9 | 14.7 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
4.8 | 14.4 | GO:1902161 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) positive regulation of establishment of Sertoli cell barrier(GO:1904446) negative regulation of type B pancreatic cell development(GO:2000077) |
4.7 | 37.6 | GO:0015871 | choline transport(GO:0015871) |
4.6 | 36.9 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
4.6 | 23.0 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
4.5 | 13.4 | GO:0006218 | uridine catabolic process(GO:0006218) uridine metabolic process(GO:0046108) |
4.4 | 44.3 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
4.4 | 26.5 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
4.4 | 13.1 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
4.3 | 13.0 | GO:0015881 | creatine transport(GO:0015881) |
4.3 | 21.7 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
4.3 | 51.2 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
4.3 | 21.3 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
4.2 | 16.8 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
4.2 | 54.5 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
4.2 | 8.4 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
4.2 | 16.7 | GO:0061206 | regulation of pronephros size(GO:0035565) mesonephros morphogenesis(GO:0061206) mesonephric nephron development(GO:0061215) mesonephric nephron morphogenesis(GO:0061228) mesenchymal stem cell maintenance involved in mesonephric nephron morphogenesis(GO:0061235) regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:0061295) negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:0061296) mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:1901146) |
4.1 | 12.4 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
4.1 | 12.3 | GO:0061623 | glycolytic process from galactose(GO:0061623) |
4.0 | 15.9 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
4.0 | 4.0 | GO:0002777 | antimicrobial peptide biosynthetic process(GO:0002777) antibacterial peptide biosynthetic process(GO:0002780) |
3.9 | 15.5 | GO:0042335 | cuticle development(GO:0042335) |
3.9 | 15.5 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
3.8 | 34.3 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
3.7 | 18.7 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
3.7 | 11.1 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
3.7 | 40.2 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
3.7 | 36.5 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
3.7 | 25.6 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
3.6 | 36.3 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
3.6 | 7.2 | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
3.6 | 10.7 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
3.6 | 10.7 | GO:0040010 | positive regulation of growth rate(GO:0040010) |
3.5 | 21.1 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
3.5 | 38.5 | GO:0035878 | nail development(GO:0035878) |
3.5 | 31.2 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
3.5 | 6.9 | GO:0060423 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
3.5 | 34.6 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
3.4 | 10.2 | GO:0032218 | riboflavin transport(GO:0032218) |
3.4 | 10.1 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
3.4 | 26.9 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
3.3 | 13.3 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
3.3 | 23.3 | GO:0072092 | ureteric bud invasion(GO:0072092) |
3.3 | 19.9 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
3.3 | 36.5 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
3.3 | 9.8 | GO:0048817 | negative regulation of hair follicle maturation(GO:0048817) |
3.2 | 25.5 | GO:0015705 | iodide transport(GO:0015705) |
3.2 | 15.9 | GO:1904970 | brush border assembly(GO:1904970) |
3.2 | 12.6 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
3.1 | 12.6 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
3.1 | 18.8 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
3.1 | 12.4 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
3.1 | 9.3 | GO:0035874 | amiloride transport(GO:0015898) cellular response to copper ion starvation(GO:0035874) response to azide(GO:0097184) cellular response to azide(GO:0097185) |
3.1 | 27.7 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
3.1 | 15.3 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
3.1 | 3.1 | GO:1904753 | negative regulation of vascular associated smooth muscle cell migration(GO:1904753) |
3.0 | 9.1 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
3.0 | 87.9 | GO:0031424 | keratinization(GO:0031424) |
3.0 | 20.9 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
3.0 | 35.8 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
3.0 | 23.8 | GO:2000665 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
3.0 | 8.9 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
3.0 | 3.0 | GO:0060157 | urinary bladder development(GO:0060157) |
2.9 | 8.8 | GO:0019388 | galactose catabolic process(GO:0019388) |
2.9 | 52.4 | GO:1902414 | protein localization to cell junction(GO:1902414) |
2.8 | 5.7 | GO:0045338 | farnesyl diphosphate metabolic process(GO:0045338) |
2.8 | 25.4 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
2.8 | 22.5 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
2.8 | 11.2 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
2.8 | 16.8 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
2.8 | 122.5 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
2.8 | 2.8 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
2.8 | 5.6 | GO:2000814 | positive regulation of barbed-end actin filament capping(GO:2000814) |
2.8 | 13.9 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
2.7 | 19.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
2.7 | 48.7 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
2.7 | 18.6 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
2.6 | 15.8 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
2.6 | 10.5 | GO:2000657 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
2.6 | 5.2 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
2.6 | 34.0 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
2.6 | 10.4 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
2.6 | 10.4 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
2.6 | 23.1 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
2.6 | 7.7 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
2.6 | 7.7 | GO:0033577 | protein glycosylation in endoplasmic reticulum(GO:0033577) |
2.5 | 48.2 | GO:0031268 | pseudopodium organization(GO:0031268) |
2.5 | 7.6 | GO:1900158 | negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
2.5 | 7.5 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
2.5 | 5.0 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
2.5 | 7.4 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
2.5 | 24.6 | GO:0048251 | elastic fiber assembly(GO:0048251) |
2.4 | 26.9 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
2.4 | 9.7 | GO:0061377 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
2.4 | 24.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
2.4 | 7.2 | GO:0006592 | ornithine biosynthetic process(GO:0006592) |
2.4 | 28.6 | GO:0030913 | paranodal junction assembly(GO:0030913) |
2.4 | 120.2 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
2.3 | 7.0 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
2.3 | 7.0 | GO:0008204 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
2.3 | 14.0 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
2.3 | 16.3 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
2.3 | 13.8 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
2.3 | 55.0 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
2.3 | 16.0 | GO:0060309 | elastin catabolic process(GO:0060309) |
2.3 | 9.1 | GO:0046083 | adenine salvage(GO:0006168) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
2.3 | 6.8 | GO:0031133 | regulation of axon diameter(GO:0031133) |
2.2 | 8.9 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
2.2 | 41.8 | GO:0002070 | epithelial cell maturation(GO:0002070) |
2.2 | 6.6 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
2.2 | 6.5 | GO:0006589 | octopamine biosynthetic process(GO:0006589) octopamine metabolic process(GO:0046333) |
2.1 | 6.4 | GO:1904635 | glomerular visceral epithelial cell apoptotic process(GO:1903210) regulation of glomerular visceral epithelial cell apoptotic process(GO:1904633) positive regulation of glomerular visceral epithelial cell apoptotic process(GO:1904635) positive regulation of progesterone biosynthetic process(GO:2000184) |
2.1 | 6.4 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) lateral motor column neuron migration(GO:0097477) |
2.1 | 21.3 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
2.1 | 4.2 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
2.1 | 2.1 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
2.1 | 14.4 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
2.1 | 14.4 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
2.0 | 10.1 | GO:0031438 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
2.0 | 38.2 | GO:0070831 | basement membrane assembly(GO:0070831) |
2.0 | 7.9 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
2.0 | 27.8 | GO:0033623 | regulation of integrin activation(GO:0033623) |
1.9 | 5.8 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
1.9 | 3.8 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
1.9 | 1.9 | GO:1900275 | negative regulation of phospholipase C activity(GO:1900275) |
1.9 | 1.9 | GO:0051665 | membrane raft localization(GO:0051665) |
1.9 | 9.4 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
1.9 | 22.5 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
1.9 | 24.2 | GO:0071493 | cellular response to UV-B(GO:0071493) |
1.9 | 20.4 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
1.8 | 14.7 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
1.8 | 16.5 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
1.8 | 5.5 | GO:0046133 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) pyrimidine ribonucleoside catabolic process(GO:0046133) |
1.8 | 3.7 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
1.8 | 3.6 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
1.8 | 1.8 | GO:1901963 | regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901963) |
1.8 | 7.2 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
1.8 | 7.2 | GO:0031662 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
1.8 | 1.8 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
1.8 | 8.9 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
1.8 | 97.9 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
1.7 | 5.2 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
1.7 | 22.6 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
1.7 | 22.5 | GO:0010650 | positive regulation of cell communication by electrical coupling(GO:0010650) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
1.7 | 12.1 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
1.7 | 6.9 | GO:0006116 | NADH oxidation(GO:0006116) |
1.7 | 8.6 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
1.7 | 36.2 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
1.7 | 6.8 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
1.7 | 6.8 | GO:0071586 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
1.7 | 27.3 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
1.7 | 6.8 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
1.7 | 6.8 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
1.7 | 1.7 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
1.7 | 6.7 | GO:0042908 | xenobiotic transport(GO:0042908) |
1.7 | 6.7 | GO:0035926 | chemokine (C-C motif) ligand 2 secretion(GO:0035926) |
1.6 | 1.6 | GO:0070194 | synaptonemal complex disassembly(GO:0070194) |
1.6 | 16.2 | GO:0046514 | ceramide catabolic process(GO:0046514) |
1.6 | 8.1 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
1.6 | 30.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
1.6 | 77.5 | GO:0007032 | endosome organization(GO:0007032) |
1.6 | 7.9 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
1.5 | 1.5 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
1.5 | 18.5 | GO:0016139 | glycoside catabolic process(GO:0016139) |
1.5 | 12.4 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
1.5 | 3.1 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
1.5 | 7.7 | GO:0098957 | anterograde axonal transport of mitochondrion(GO:0098957) |
1.5 | 1.5 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
1.5 | 4.6 | GO:0016598 | protein arginylation(GO:0016598) |
1.5 | 4.6 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
1.5 | 6.1 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
1.5 | 3.0 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
1.5 | 9.1 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
1.5 | 91.4 | GO:1903078 | positive regulation of protein localization to plasma membrane(GO:1903078) |
1.5 | 1.5 | GO:0002930 | trabecular meshwork development(GO:0002930) |
1.5 | 6.0 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
1.5 | 14.9 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
1.5 | 7.4 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
1.5 | 1.5 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
1.5 | 8.9 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
1.5 | 13.2 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
1.5 | 19.1 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
1.5 | 7.3 | GO:0070314 | G1 to G0 transition(GO:0070314) |
1.5 | 26.3 | GO:0060056 | mammary gland involution(GO:0060056) |
1.4 | 10.1 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
1.4 | 4.3 | GO:0071335 | hair follicle cell proliferation(GO:0071335) |
1.4 | 2.9 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
1.4 | 1.4 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
1.4 | 5.7 | GO:1902045 | regulation of Fas signaling pathway(GO:1902044) negative regulation of Fas signaling pathway(GO:1902045) |
1.4 | 4.3 | GO:0010752 | regulation of cGMP-mediated signaling(GO:0010752) |
1.4 | 4.2 | GO:0034148 | regulation of granuloma formation(GO:0002631) negative regulation of granuloma formation(GO:0002632) regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) |
1.4 | 2.8 | GO:1904673 | pronephric field specification(GO:0039003) pattern specification involved in pronephros development(GO:0039017) kidney field specification(GO:0072004) regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072039) negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072040) regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072304) negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072305) mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) apoptotic process involved in metanephric collecting duct development(GO:1900204) apoptotic process involved in metanephric nephron tubule development(GO:1900205) regulation of apoptotic process involved in metanephric collecting duct development(GO:1900214) negative regulation of apoptotic process involved in metanephric collecting duct development(GO:1900215) regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900217) negative regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900218) mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:1901145) mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:1901147) negative regulation of somatic stem cell population maintenance(GO:1904673) regulation of metanephric DCT cell differentiation(GO:2000592) positive regulation of metanephric DCT cell differentiation(GO:2000594) |
1.4 | 19.6 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
1.4 | 5.6 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
1.4 | 1.4 | GO:2001205 | negative regulation of osteoclast development(GO:2001205) |
1.4 | 1.4 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
1.4 | 2.8 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
1.4 | 2.7 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
1.4 | 5.5 | GO:0006710 | androgen catabolic process(GO:0006710) |
1.4 | 40.8 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
1.4 | 6.8 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
1.3 | 5.4 | GO:0090346 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
1.3 | 5.3 | GO:0035672 | dipeptide transmembrane transport(GO:0035442) oligopeptide transmembrane transport(GO:0035672) regulation of oligopeptide transport(GO:0090088) regulation of dipeptide transport(GO:0090089) positive regulation of oligopeptide transport(GO:2000878) positive regulation of dipeptide transport(GO:2000880) regulation of dipeptide transmembrane transport(GO:2001148) positive regulation of dipeptide transmembrane transport(GO:2001150) |
1.3 | 4.0 | GO:0003383 | apical constriction(GO:0003383) |
1.3 | 3.9 | GO:0045362 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
1.3 | 1.3 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
1.3 | 3.9 | GO:0098917 | retrograde trans-synaptic signaling(GO:0098917) |
1.3 | 7.7 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
1.3 | 6.4 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
1.3 | 3.8 | GO:0060032 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) notochord regression(GO:0060032) |
1.3 | 2.6 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.3 | 11.5 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
1.3 | 11.4 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
1.3 | 24.0 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
1.3 | 3.8 | GO:0060464 | lung lobe formation(GO:0060464) diaphragm morphogenesis(GO:0060540) |
1.3 | 8.8 | GO:0030035 | microspike assembly(GO:0030035) |
1.2 | 5.0 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
1.2 | 3.7 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
1.2 | 7.5 | GO:0042256 | mature ribosome assembly(GO:0042256) |
1.2 | 6.1 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
1.2 | 7.3 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
1.2 | 3.7 | GO:0042938 | dipeptide transport(GO:0042938) |
1.2 | 24.4 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
1.2 | 4.9 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
1.2 | 1.2 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
1.2 | 7.3 | GO:0015889 | cobalamin transport(GO:0015889) |
1.2 | 10.9 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
1.2 | 4.8 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
1.2 | 3.6 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
1.2 | 11.9 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
1.2 | 6.0 | GO:1905035 | regulation of antifungal innate immune response(GO:1905034) negative regulation of antifungal innate immune response(GO:1905035) |
1.2 | 15.4 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
1.2 | 8.3 | GO:1903232 | melanosome assembly(GO:1903232) |
1.2 | 9.4 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
1.2 | 7.0 | GO:0042637 | catagen(GO:0042637) |
1.2 | 3.5 | GO:0018900 | dichloromethane metabolic process(GO:0018900) |
1.2 | 3.5 | GO:1901003 | negative regulation of fermentation(GO:1901003) |
1.2 | 15.2 | GO:0090195 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) |
1.2 | 1.2 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
1.2 | 9.3 | GO:0097178 | ruffle assembly(GO:0097178) |
1.2 | 3.5 | GO:0036245 | cellular response to menadione(GO:0036245) |
1.2 | 8.1 | GO:0016264 | gap junction assembly(GO:0016264) |
1.2 | 23.0 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
1.1 | 2.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
1.1 | 4.6 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
1.1 | 4.5 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
1.1 | 6.7 | GO:0044351 | macropinocytosis(GO:0044351) |
1.1 | 82.7 | GO:0006970 | response to osmotic stress(GO:0006970) |
1.1 | 3.4 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
1.1 | 1.1 | GO:0071726 | response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
1.1 | 5.6 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
1.1 | 3.3 | GO:0048162 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
1.1 | 3.3 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
1.1 | 1.1 | GO:0039019 | pronephric nephron development(GO:0039019) |
1.1 | 10.0 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
1.1 | 4.4 | GO:0071321 | negative regulation of cerebellar granule cell precursor proliferation(GO:0021941) sperm ejaculation(GO:0042713) cellular response to cGMP(GO:0071321) |
1.1 | 2.2 | GO:0019323 | pentose catabolic process(GO:0019323) |
1.1 | 3.3 | GO:0001788 | antibody-dependent cellular cytotoxicity(GO:0001788) |
1.1 | 4.4 | GO:0043589 | skin morphogenesis(GO:0043589) |
1.1 | 2.2 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
1.1 | 13.1 | GO:0070633 | transepithelial transport(GO:0070633) |
1.1 | 9.8 | GO:0045176 | apical protein localization(GO:0045176) |
1.1 | 30.4 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
1.1 | 4.3 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
1.1 | 1.1 | GO:0061760 | antifungal innate immune response(GO:0061760) |
1.1 | 16.1 | GO:0031529 | ruffle organization(GO:0031529) |
1.1 | 7.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
1.1 | 1.1 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) |
1.0 | 3.1 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
1.0 | 31.1 | GO:0007043 | cell-cell junction assembly(GO:0007043) |
1.0 | 2.1 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
1.0 | 4.1 | GO:0048165 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
1.0 | 4.1 | GO:1903575 | cornified envelope assembly(GO:1903575) |
1.0 | 4.1 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
1.0 | 5.2 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
1.0 | 5.1 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
1.0 | 1.0 | GO:2000303 | regulation of ceramide biosynthetic process(GO:2000303) |
1.0 | 12.2 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
1.0 | 16.1 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
1.0 | 11.1 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
1.0 | 2.0 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
1.0 | 2.0 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
1.0 | 8.0 | GO:0036315 | cellular response to sterol(GO:0036315) |
1.0 | 14.0 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
1.0 | 2.0 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
1.0 | 3.0 | GO:0030070 | insulin processing(GO:0030070) |
1.0 | 15.0 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
1.0 | 6.0 | GO:0018094 | protein polyglycylation(GO:0018094) |
1.0 | 5.0 | GO:0044727 | DNA demethylation of male pronucleus(GO:0044727) |
1.0 | 1.0 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
1.0 | 2.0 | GO:0035627 | ceramide transport(GO:0035627) |
1.0 | 7.9 | GO:1902959 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) regulation of aspartic-type peptidase activity(GO:1905245) |
1.0 | 3.0 | GO:0015825 | L-serine transport(GO:0015825) |
1.0 | 3.9 | GO:2000373 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
1.0 | 5.8 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
1.0 | 4.9 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
1.0 | 1.9 | GO:0002344 | B cell selection(GO:0002339) peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
1.0 | 2.9 | GO:2000843 | testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) |
1.0 | 3.8 | GO:0051866 | general adaptation syndrome(GO:0051866) |
1.0 | 7.6 | GO:0002066 | columnar/cuboidal epithelial cell development(GO:0002066) |
0.9 | 4.7 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.9 | 0.9 | GO:0072162 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) metanephric mesenchymal cell differentiation(GO:0072162) |
0.9 | 3.8 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
0.9 | 11.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.9 | 1.9 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
0.9 | 3.7 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.9 | 2.8 | GO:0045643 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
0.9 | 3.7 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.9 | 0.9 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.9 | 2.8 | GO:0070859 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
0.9 | 7.4 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) negative regulation of neutrophil activation(GO:1902564) |
0.9 | 1.8 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.9 | 2.7 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.9 | 3.6 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.9 | 4.5 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.9 | 9.9 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.9 | 5.4 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.9 | 2.7 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.9 | 0.9 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.9 | 13.4 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.9 | 2.7 | GO:0043323 | positive regulation of natural killer cell degranulation(GO:0043323) |
0.9 | 3.6 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.9 | 3.6 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.9 | 2.7 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.9 | 3.5 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.9 | 1.7 | GO:1902524 | positive regulation of protein K48-linked ubiquitination(GO:1902524) |
0.9 | 4.3 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.9 | 2.6 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
0.9 | 7.7 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.8 | 1.7 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.8 | 5.0 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.8 | 2.5 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.8 | 12.6 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.8 | 11.7 | GO:0006465 | signal peptide processing(GO:0006465) |
0.8 | 14.8 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.8 | 4.1 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.8 | 12.4 | GO:0036065 | fucosylation(GO:0036065) |
0.8 | 16.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.8 | 4.9 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.8 | 1.6 | GO:0002352 | B cell negative selection(GO:0002352) |
0.8 | 4.0 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.8 | 1.6 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.8 | 4.0 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.8 | 7.2 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
0.8 | 7.1 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.8 | 2.4 | GO:1904093 | regulation of autophagic cell death(GO:1904092) negative regulation of autophagic cell death(GO:1904093) |
0.8 | 0.8 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.8 | 2.3 | GO:0034201 | response to oleic acid(GO:0034201) |
0.8 | 3.1 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.8 | 11.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.8 | 6.1 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.8 | 2.3 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.8 | 2.3 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
0.8 | 0.8 | GO:0009838 | abscission(GO:0009838) |
0.8 | 3.8 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
0.7 | 1.5 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.7 | 109.1 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.7 | 5.2 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.7 | 10.3 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.7 | 2.2 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.7 | 1.5 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.7 | 3.6 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.7 | 1.5 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.7 | 1.4 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.7 | 0.7 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.7 | 3.6 | GO:0003404 | optic vesicle morphogenesis(GO:0003404) |
0.7 | 4.3 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.7 | 1.4 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.7 | 1.4 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.7 | 46.9 | GO:0030216 | keratinocyte differentiation(GO:0030216) |
0.7 | 6.4 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.7 | 2.1 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.7 | 12.0 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.7 | 0.7 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.7 | 2.8 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.7 | 9.1 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.7 | 2.1 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.7 | 0.7 | GO:0097490 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.7 | 7.6 | GO:2001028 | positive regulation of endothelial cell chemotaxis(GO:2001028) |
0.7 | 3.5 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.7 | 2.1 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.7 | 4.8 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.7 | 3.4 | GO:0046110 | xanthine metabolic process(GO:0046110) |
0.7 | 19.0 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.7 | 7.4 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.7 | 2.7 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.7 | 2.0 | GO:0097475 | motor neuron migration(GO:0097475) |
0.7 | 1.3 | GO:0000915 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
0.7 | 2.0 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.7 | 7.9 | GO:0033572 | transferrin transport(GO:0033572) |
0.7 | 0.7 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.7 | 5.9 | GO:0006108 | malate metabolic process(GO:0006108) |
0.7 | 0.7 | GO:0043585 | nose morphogenesis(GO:0043585) |
0.7 | 1.3 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.7 | 2.0 | GO:0099526 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
0.7 | 2.0 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.7 | 8.5 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.7 | 4.6 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.7 | 30.0 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.7 | 2.6 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.7 | 1.3 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.6 | 11.6 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.6 | 9.6 | GO:1901028 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901028) |
0.6 | 5.1 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.6 | 1.9 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.6 | 2.5 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.6 | 14.6 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.6 | 2.5 | GO:0070459 | prolactin secretion(GO:0070459) |
0.6 | 8.2 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.6 | 1.9 | GO:1904468 | negative regulation of tumor necrosis factor secretion(GO:1904468) |
0.6 | 3.1 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.6 | 18.1 | GO:1905144 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.6 | 3.1 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.6 | 2.5 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.6 | 18.6 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.6 | 9.3 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.6 | 3.1 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.6 | 1.2 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.6 | 1.8 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.6 | 3.7 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.6 | 3.0 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.6 | 4.8 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.6 | 16.7 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.6 | 0.6 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.6 | 1.8 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.6 | 4.1 | GO:0051775 | response to redox state(GO:0051775) |
0.6 | 2.3 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.6 | 1.8 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.6 | 5.8 | GO:0030432 | peristalsis(GO:0030432) |
0.6 | 9.3 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.6 | 22.0 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) |
0.6 | 9.2 | GO:0032060 | bleb assembly(GO:0032060) |
0.6 | 1.7 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.6 | 2.9 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.6 | 0.6 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.6 | 4.0 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.6 | 4.5 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
0.6 | 3.4 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.6 | 1.7 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.6 | 1.7 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.6 | 3.9 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.5 | 11.0 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.5 | 0.5 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
0.5 | 1.1 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.5 | 2.7 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.5 | 13.6 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.5 | 7.0 | GO:0014850 | response to muscle activity(GO:0014850) |
0.5 | 1.6 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.5 | 3.2 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.5 | 4.8 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.5 | 1.1 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.5 | 1.6 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.5 | 2.6 | GO:0035549 | interferon-beta secretion(GO:0035546) regulation of interferon-beta secretion(GO:0035547) positive regulation of interferon-beta secretion(GO:0035549) |
0.5 | 5.8 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.5 | 2.6 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.5 | 1.6 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
0.5 | 2.6 | GO:0009177 | dTMP biosynthetic process(GO:0006231) deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) dTMP metabolic process(GO:0046073) |
0.5 | 0.5 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
0.5 | 7.3 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.5 | 2.1 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.5 | 2.6 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
0.5 | 1.5 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.5 | 2.0 | GO:0014857 | skeletal muscle cell proliferation(GO:0014856) regulation of skeletal muscle cell proliferation(GO:0014857) |
0.5 | 3.5 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.5 | 0.5 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.5 | 2.5 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.5 | 1.0 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.5 | 4.5 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.5 | 1.5 | GO:0018003 | peptidyl-lysine N6-acetylation(GO:0018003) |
0.5 | 1.5 | GO:2000422 | regulation of eosinophil chemotaxis(GO:2000422) positive regulation of eosinophil chemotaxis(GO:2000424) |
0.5 | 5.4 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.5 | 2.4 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.5 | 6.3 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.5 | 1.4 | GO:0031104 | dendrite regeneration(GO:0031104) |
0.5 | 7.1 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.5 | 2.4 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.5 | 2.8 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.5 | 0.5 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.5 | 1.9 | GO:0051572 | negative regulation of histone H3-K36 methylation(GO:0000415) negative regulation of histone H3-K4 methylation(GO:0051572) |
0.5 | 6.6 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.5 | 1.4 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.5 | 3.3 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.5 | 3.7 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.5 | 6.5 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.5 | 3.7 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.5 | 0.9 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.5 | 7.7 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
0.5 | 4.5 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.5 | 1.4 | GO:0002003 | angiotensin maturation(GO:0002003) |
0.5 | 5.9 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.5 | 9.5 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
0.4 | 6.3 | GO:0032506 | cytokinetic process(GO:0032506) |
0.4 | 93.6 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.4 | 0.9 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) |
0.4 | 0.9 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.4 | 21.7 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.4 | 2.7 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.4 | 2.2 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.4 | 7.9 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.4 | 2.2 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.4 | 16.9 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.4 | 3.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.4 | 2.1 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.4 | 7.7 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.4 | 0.9 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.4 | 6.8 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.4 | 2.1 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.4 | 0.9 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.4 | 2.1 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.4 | 5.9 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.4 | 5.8 | GO:0010039 | response to iron ion(GO:0010039) |
0.4 | 5.4 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
0.4 | 0.8 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.4 | 0.4 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.4 | 1.6 | GO:0014889 | muscle atrophy(GO:0014889) |
0.4 | 2.0 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.4 | 0.8 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.4 | 8.8 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.4 | 2.4 | GO:0051013 | microtubule severing(GO:0051013) |
0.4 | 8.7 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
0.4 | 9.1 | GO:0006491 | N-glycan processing(GO:0006491) |
0.4 | 10.3 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.4 | 0.8 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.4 | 2.0 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.4 | 0.8 | GO:1902285 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.4 | 7.8 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.4 | 1.9 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.4 | 1.2 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.4 | 1.9 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.4 | 5.7 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.4 | 1.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.4 | 1.1 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.4 | 1.1 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.4 | 1.1 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.4 | 1.5 | GO:0009744 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.4 | 1.5 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
0.4 | 1.5 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.4 | 6.7 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.4 | 0.4 | GO:0001743 | optic placode formation(GO:0001743) |
0.4 | 5.9 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.4 | 2.9 | GO:0019695 | choline metabolic process(GO:0019695) |
0.4 | 1.1 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.4 | 1.1 | GO:0090383 | phagosome acidification(GO:0090383) |
0.4 | 1.1 | GO:0032570 | response to progesterone(GO:0032570) |
0.4 | 1.4 | GO:0002268 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.4 | 0.7 | GO:0048822 | enucleate erythrocyte development(GO:0048822) |
0.4 | 13.5 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.4 | 2.1 | GO:1901563 | response to camptothecin(GO:1901563) |
0.4 | 2.5 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.4 | 0.7 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.4 | 1.4 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
0.4 | 2.1 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.4 | 1.1 | GO:0097052 | L-kynurenine metabolic process(GO:0097052) |
0.3 | 4.5 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.3 | 1.4 | GO:0044036 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.3 | 1.4 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.3 | 3.5 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.3 | 0.3 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) |
0.3 | 2.8 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.3 | 12.4 | GO:0061180 | mammary gland epithelium development(GO:0061180) |
0.3 | 0.7 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.3 | 3.4 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.3 | 1.4 | GO:0032468 | cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
0.3 | 1.0 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.3 | 3.7 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.3 | 1.0 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.3 | 1.0 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.3 | 1.7 | GO:0060253 | negative regulation of glial cell proliferation(GO:0060253) |
0.3 | 0.3 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.3 | 3.3 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.3 | 0.7 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.3 | 5.6 | GO:0002067 | glandular epithelial cell differentiation(GO:0002067) |
0.3 | 1.9 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.3 | 17.9 | GO:0007586 | digestion(GO:0007586) |
0.3 | 1.3 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.3 | 6.9 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.3 | 5.0 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.3 | 1.2 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.3 | 1.8 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.3 | 1.2 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
0.3 | 3.6 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.3 | 1.5 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.3 | 0.6 | GO:0045054 | constitutive secretory pathway(GO:0045054) regulation of constitutive secretory pathway(GO:1903433) |
0.3 | 6.5 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.3 | 1.2 | GO:0061181 | regulation of chondrocyte development(GO:0061181) |
0.3 | 3.8 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.3 | 0.9 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.3 | 1.8 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.3 | 1.2 | GO:0090096 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) lactic acid secretion(GO:0046722) kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
0.3 | 2.3 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.3 | 8.4 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.3 | 0.9 | GO:0061090 | positive regulation of sequestering of zinc ion(GO:0061090) |
0.3 | 0.6 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.3 | 9.4 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.3 | 4.3 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.3 | 2.8 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.3 | 2.3 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.3 | 1.4 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.3 | 0.6 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.3 | 1.7 | GO:1904738 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.3 | 4.4 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.3 | 1.9 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.3 | 2.7 | GO:0051601 | exocyst localization(GO:0051601) |
0.3 | 1.4 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.3 | 0.3 | GO:0044805 | late nucleophagy(GO:0044805) |
0.3 | 0.3 | GO:0061724 | lipophagy(GO:0061724) regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) regulation of intracellular mRNA localization(GO:1904580) |
0.3 | 1.1 | GO:0010446 | response to alkaline pH(GO:0010446) cellular response to alkaline pH(GO:0071469) |
0.3 | 2.1 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.3 | 8.2 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.3 | 0.5 | GO:1990000 | amyloid fibril formation(GO:1990000) |
0.3 | 1.6 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.3 | 1.5 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.3 | 1.3 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.3 | 1.5 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.3 | 0.5 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.3 | 4.0 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
0.2 | 3.2 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.2 | 0.7 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.2 | 1.7 | GO:2000674 | regulation of type B pancreatic cell apoptotic process(GO:2000674) negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.2 | 1.2 | GO:0006983 | ER overload response(GO:0006983) |
0.2 | 2.2 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.2 | 7.7 | GO:0009409 | response to cold(GO:0009409) |
0.2 | 1.2 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.2 | 1.2 | GO:0060581 | ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.2 | 8.7 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.2 | 4.5 | GO:0034063 | stress granule assembly(GO:0034063) |
0.2 | 5.2 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.2 | 1.4 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
0.2 | 1.4 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.2 | 1.2 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.2 | 1.6 | GO:0007527 | adult somatic muscle development(GO:0007527) |
0.2 | 0.7 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.2 | 1.8 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.2 | 0.7 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.2 | 2.3 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.2 | 2.3 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.2 | 8.8 | GO:0048278 | vesicle docking(GO:0048278) |
0.2 | 1.4 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.2 | 0.4 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.2 | 0.7 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
0.2 | 2.4 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.2 | 0.7 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.2 | 2.2 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.2 | 1.3 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.2 | 1.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.2 | 3.5 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.2 | 4.1 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.2 | 0.8 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
0.2 | 8.3 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.2 | 1.9 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.2 | 0.6 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.2 | 0.6 | GO:0043519 | myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
0.2 | 0.2 | GO:0042262 | DNA protection(GO:0042262) |
0.2 | 3.9 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.2 | 0.6 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.2 | 0.4 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) regulation of engulfment of apoptotic cell(GO:1901074) |
0.2 | 1.0 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 2.0 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.2 | 1.0 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.2 | 12.0 | GO:0090277 | positive regulation of peptide hormone secretion(GO:0090277) |
0.2 | 1.5 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.2 | 4.8 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.2 | 1.1 | GO:0006113 | fermentation(GO:0006113) |
0.2 | 0.2 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.2 | 0.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.2 | 1.9 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.2 | 2.4 | GO:0030903 | notochord development(GO:0030903) |
0.2 | 0.7 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.2 | 1.3 | GO:0070842 | aggresome assembly(GO:0070842) |
0.2 | 0.9 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.2 | 1.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 9.8 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.2 | 0.4 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
0.2 | 2.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.2 | 1.9 | GO:2000058 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000058) |
0.2 | 0.3 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.2 | 0.7 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.2 | 1.7 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.2 | 1.0 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.2 | 1.2 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.2 | 2.6 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.2 | 1.0 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
0.2 | 1.0 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.2 | 0.5 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.2 | 5.6 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.2 | 0.8 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.2 | 0.3 | GO:0048880 | sensory system development(GO:0048880) |
0.2 | 2.7 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.2 | 0.5 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
0.2 | 0.6 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.2 | 0.8 | GO:0032075 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) positive regulation of nuclease activity(GO:0032075) |
0.2 | 1.4 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.2 | 1.4 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.2 | 1.3 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.2 | 0.6 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.2 | 0.6 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.2 | 0.8 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
0.2 | 0.8 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.2 | 1.4 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.2 | 1.1 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.2 | 0.5 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.2 | 1.5 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.2 | 0.5 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
0.2 | 1.7 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.1 | 0.7 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 1.2 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
0.1 | 4.8 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 0.9 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 0.3 | GO:1904953 | Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904953) |
0.1 | 1.4 | GO:0030033 | microvillus assembly(GO:0030033) |
0.1 | 0.1 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.1 | 0.6 | GO:0060785 | regulation of apoptosis involved in tissue homeostasis(GO:0060785) |
0.1 | 0.3 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.1 | 0.3 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.8 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 3.0 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.1 | 9.9 | GO:0045807 | positive regulation of endocytosis(GO:0045807) |
0.1 | 1.5 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.5 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.1 | 0.1 | GO:0036499 | PERK-mediated unfolded protein response(GO:0036499) |
0.1 | 0.1 | GO:0044725 | chromatin reprogramming in the zygote(GO:0044725) |
0.1 | 0.7 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 0.5 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.1 | 0.5 | GO:0072401 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.1 | 0.9 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.6 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.1 | 4.1 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 1.0 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 | 1.4 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.1 | 0.4 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 2.4 | GO:0008347 | glial cell migration(GO:0008347) |
0.1 | 0.6 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.7 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.5 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.6 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 1.5 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 1.9 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.1 | 0.5 | GO:0035106 | operant conditioning(GO:0035106) |
0.1 | 1.8 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 2.2 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 1.4 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.1 | 0.3 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.1 | 2.7 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.1 | 0.3 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.1 | 1.5 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 0.3 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.1 | 0.4 | GO:0097421 | liver regeneration(GO:0097421) |
0.1 | 0.9 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.1 | 0.5 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.4 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.1 | 0.8 | GO:0009405 | pathogenesis(GO:0009405) |
0.1 | 1.0 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.1 | 0.5 | GO:0048313 | Golgi inheritance(GO:0048313) |
0.1 | 16.1 | GO:0070507 | regulation of microtubule cytoskeleton organization(GO:0070507) |
0.1 | 0.8 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.1 | 0.3 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.1 | 1.6 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.7 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.1 | 5.6 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.3 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.1 | 0.1 | GO:0060426 | lung vasculature development(GO:0060426) |
0.1 | 1.5 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 1.8 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 1.1 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.4 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.1 | 0.5 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.3 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.1 | 0.2 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 0.5 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 0.3 | GO:0060151 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
0.1 | 0.2 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.1 | 1.7 | GO:0097034 | mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.1 | 1.6 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
0.1 | 0.5 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.9 | GO:0046051 | UTP metabolic process(GO:0046051) |
0.1 | 0.5 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 2.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.6 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.1 | 0.3 | GO:0007619 | courtship behavior(GO:0007619) female courtship behavior(GO:0008050) |
0.1 | 0.3 | GO:0006429 | leucyl-tRNA aminoacylation(GO:0006429) |
0.1 | 0.5 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.1 | 0.2 | GO:2000011 | adaxial/abaxial pattern specification(GO:0009955) regulation of adaxial/abaxial pattern formation(GO:2000011) |
0.1 | 0.5 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.2 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 0.6 | GO:0034773 | histone H4-K20 methylation(GO:0034770) histone H4-K20 trimethylation(GO:0034773) |
0.1 | 0.3 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.1 | 4.6 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 1.5 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.1 | 0.7 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.1 | 0.1 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.1 | 0.6 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.1 | 0.6 | GO:0001523 | retinoid metabolic process(GO:0001523) |
0.1 | 0.1 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 0.9 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.4 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.1 | 0.4 | GO:0036343 | psychomotor behavior(GO:0036343) |
0.1 | 0.2 | GO:0006583 | melanin biosynthetic process from tyrosine(GO:0006583) |
0.1 | 1.3 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 0.7 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.1 | 0.4 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) |
0.1 | 1.6 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 2.2 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.1 | 0.6 | GO:0061307 | cardiac neural crest cell differentiation involved in heart development(GO:0061307) |
0.1 | 0.7 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 0.5 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.1 | 0.4 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.1 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
0.1 | 0.2 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.1 | 0.5 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.2 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 0.2 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.1 | 6.3 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.4 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.3 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.1 | 0.2 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.1 | 0.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.2 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.1 | 0.2 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
0.1 | 0.4 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.4 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) |
0.1 | 0.9 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 0.4 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.1 | 0.2 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.1 | 0.4 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 0.7 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.0 | GO:1904429 | regulation of t-circle formation(GO:1904429) positive regulation of t-circle formation(GO:1904431) |
0.0 | 0.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.0 | 0.4 | GO:0051905 | establishment of melanosome localization(GO:0032401) establishment of pigment granule localization(GO:0051905) |
0.0 | 0.2 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
0.0 | 2.0 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.1 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.0 | 0.1 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
0.0 | 0.1 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.0 | 0.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.1 | GO:0030472 | mitotic spindle organization in nucleus(GO:0030472) |
0.0 | 0.5 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.0 | 3.9 | GO:2000045 | regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
0.0 | 0.6 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.2 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.0 | 0.4 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.2 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.0 | 0.3 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.1 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.0 | 0.2 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.0 | 0.1 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.0 | 0.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.2 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 0.1 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.0 | 0.1 | GO:0060912 | cardiac cell fate specification(GO:0060912) |
0.0 | 0.2 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.2 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.0 | 0.3 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.0 | 0.1 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.0 | 0.1 | GO:0021778 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.0 | 0.2 | GO:1903077 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.0 | 0.1 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.0 | 0.0 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.0 | 0.6 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.0 | 0.0 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
0.0 | 0.1 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 0.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.1 | GO:0002021 | response to dietary excess(GO:0002021) |
0.0 | 0.6 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.0 | 0.1 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.0 | GO:0070668 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) negative regulation of mast cell apoptotic process(GO:0033026) mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.0 | 0.0 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
0.0 | 0.0 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 0.1 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.0 | 0.0 | GO:0000022 | mitotic spindle elongation(GO:0000022) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
21.5 | 193.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
13.4 | 120.5 | GO:1990357 | terminal web(GO:1990357) |
10.9 | 32.6 | GO:0005607 | laminin-2 complex(GO:0005607) |
10.8 | 357.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
9.6 | 47.8 | GO:0005914 | spot adherens junction(GO:0005914) |
7.8 | 85.3 | GO:0045179 | apical cortex(GO:0045179) |
7.7 | 53.6 | GO:0070695 | FHF complex(GO:0070695) |
7.1 | 28.6 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
6.7 | 39.9 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
5.3 | 16.0 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
5.2 | 78.7 | GO:0005915 | zonula adherens(GO:0005915) |
5.1 | 30.9 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
4.9 | 24.3 | GO:0005610 | laminin-5 complex(GO:0005610) |
4.6 | 64.0 | GO:0043219 | lateral loop(GO:0043219) |
4.4 | 39.7 | GO:0001651 | dense fibrillar component(GO:0001651) |
4.3 | 123.8 | GO:0030057 | desmosome(GO:0030057) |
3.9 | 65.7 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
3.9 | 19.3 | GO:0035976 | AP1 complex(GO:0035976) |
3.6 | 17.9 | GO:0044194 | cytolytic granule(GO:0044194) |
3.6 | 92.7 | GO:0032433 | filopodium tip(GO:0032433) |
3.5 | 73.1 | GO:0031143 | pseudopodium(GO:0031143) |
3.4 | 143.3 | GO:0045095 | keratin filament(GO:0045095) |
3.1 | 21.7 | GO:0071914 | prominosome(GO:0071914) |
3.0 | 94.3 | GO:0031528 | microvillus membrane(GO:0031528) |
2.9 | 95.8 | GO:0034706 | sodium channel complex(GO:0034706) |
2.8 | 5.6 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
2.7 | 511.2 | GO:0070160 | occluding junction(GO:0070160) |
2.5 | 5.0 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
2.5 | 9.9 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
2.5 | 14.8 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
2.4 | 21.8 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
2.4 | 7.2 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
2.4 | 122.8 | GO:0001533 | cornified envelope(GO:0001533) |
2.3 | 11.5 | GO:0098533 | sodium:potassium-exchanging ATPase complex(GO:0005890) cation-transporting ATPase complex(GO:0090533) ATPase dependent transmembrane transport complex(GO:0098533) |
2.2 | 107.6 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
2.2 | 4.5 | GO:0098842 | postsynaptic early endosome(GO:0098842) |
2.2 | 4.4 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
2.1 | 77.1 | GO:0042588 | zymogen granule(GO:0042588) |
2.1 | 81.2 | GO:0005921 | gap junction(GO:0005921) |
2.1 | 6.4 | GO:1990844 | subsarcolemmal mitochondrion(GO:1990843) interfibrillar mitochondrion(GO:1990844) |
2.1 | 6.2 | GO:1904602 | serotonin-activated cation-selective channel complex(GO:1904602) |
2.1 | 14.4 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
2.1 | 10.3 | GO:0071953 | elastic fiber(GO:0071953) |
2.0 | 28.5 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
2.0 | 2.0 | GO:0097226 | sperm mitochondrial sheath(GO:0097226) |
2.0 | 9.8 | GO:0097209 | epidermal lamellar body(GO:0097209) |
1.9 | 9.5 | GO:0043293 | apoptosome(GO:0043293) |
1.9 | 5.6 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
1.8 | 7.3 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
1.8 | 10.8 | GO:0031523 | Myb complex(GO:0031523) |
1.8 | 16.2 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
1.8 | 3.6 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
1.8 | 51.2 | GO:0055038 | recycling endosome membrane(GO:0055038) |
1.7 | 1.7 | GO:1902636 | kinociliary basal body(GO:1902636) |
1.7 | 26.7 | GO:0097470 | ribbon synapse(GO:0097470) |
1.7 | 25.0 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
1.6 | 19.6 | GO:0000815 | ESCRT III complex(GO:0000815) |
1.6 | 30.0 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
1.5 | 1.5 | GO:0043259 | laminin-10 complex(GO:0043259) |
1.5 | 24.4 | GO:0090543 | Flemming body(GO:0090543) |
1.5 | 7.6 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
1.4 | 4.3 | GO:0097441 | basilar dendrite(GO:0097441) |
1.4 | 14.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.4 | 11.3 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
1.4 | 1.4 | GO:0030478 | actin cap(GO:0030478) |
1.4 | 9.7 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
1.3 | 95.5 | GO:0009925 | basal plasma membrane(GO:0009925) |
1.3 | 4.0 | GO:0044299 | C-fiber(GO:0044299) |
1.3 | 14.5 | GO:0033270 | paranode region of axon(GO:0033270) |
1.3 | 79.8 | GO:0031901 | early endosome membrane(GO:0031901) |
1.3 | 6.5 | GO:0033269 | internode region of axon(GO:0033269) |
1.3 | 3.9 | GO:0032783 | ELL-EAF complex(GO:0032783) |
1.3 | 9.0 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
1.3 | 2.5 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
1.2 | 8.5 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.2 | 11.7 | GO:0005787 | signal peptidase complex(GO:0005787) |
1.2 | 140.6 | GO:0032587 | ruffle membrane(GO:0032587) |
1.1 | 4.6 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
1.1 | 140.4 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
1.1 | 2.3 | GO:0044317 | rod spherule(GO:0044317) |
1.1 | 17.4 | GO:0043296 | apical junction complex(GO:0043296) |
1.1 | 15.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
1.0 | 8.3 | GO:0043218 | compact myelin(GO:0043218) |
1.0 | 1.0 | GO:0005757 | mitochondrial permeability transition pore complex(GO:0005757) |
1.0 | 123.3 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
1.0 | 5.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
1.0 | 5.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
1.0 | 32.8 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
1.0 | 9.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
1.0 | 87.5 | GO:0005902 | microvillus(GO:0005902) |
1.0 | 3.8 | GO:0036284 | tubulobulbar complex(GO:0036284) |
0.9 | 2.8 | GO:0038045 | large latent transforming growth factor-beta complex(GO:0038045) |
0.9 | 5.6 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.9 | 4.7 | GO:0071817 | MMXD complex(GO:0071817) |
0.9 | 2.8 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
0.9 | 3.7 | GO:1990032 | parallel fiber(GO:1990032) |
0.9 | 6.4 | GO:0005638 | lamin filament(GO:0005638) |
0.9 | 10.1 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.9 | 2.7 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.9 | 23.2 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.9 | 1.7 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.9 | 19.1 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.9 | 3.5 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.9 | 3.4 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.8 | 3.4 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
0.8 | 2.5 | GO:0005584 | collagen type I trimer(GO:0005584) |
0.8 | 8.3 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.8 | 14.6 | GO:0042581 | specific granule(GO:0042581) |
0.8 | 11.3 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.8 | 11.9 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.8 | 9.0 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.7 | 2.2 | GO:0045180 | basal cortex(GO:0045180) |
0.7 | 3.6 | GO:0097443 | sorting endosome(GO:0097443) |
0.7 | 8.0 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.7 | 7.9 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.7 | 2.1 | GO:0097232 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
0.7 | 4.3 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.7 | 23.4 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.7 | 12.0 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.7 | 1.4 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.7 | 14.5 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.7 | 17.9 | GO:0031941 | filamentous actin(GO:0031941) |
0.7 | 9.6 | GO:0097386 | glial cell projection(GO:0097386) |
0.7 | 4.8 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.7 | 2.0 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
0.7 | 69.8 | GO:0072686 | mitotic spindle(GO:0072686) |
0.7 | 2.0 | GO:0031904 | endosome lumen(GO:0031904) multivesicular body, internal vesicle(GO:0097487) |
0.7 | 7.2 | GO:0031209 | SCAR complex(GO:0031209) |
0.6 | 34.6 | GO:0005884 | actin filament(GO:0005884) |
0.6 | 1.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.6 | 3.1 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.6 | 62.9 | GO:0031526 | brush border membrane(GO:0031526) |
0.6 | 7.8 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.6 | 1.8 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.6 | 2.9 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.6 | 3.4 | GO:0070938 | contractile ring(GO:0070938) |
0.6 | 1.1 | GO:0042599 | lamellar body(GO:0042599) |
0.5 | 37.6 | GO:0005795 | Golgi stack(GO:0005795) |
0.5 | 1.6 | GO:0005715 | late recombination nodule(GO:0005715) |
0.5 | 3.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.5 | 8.5 | GO:0042555 | MCM complex(GO:0042555) |
0.5 | 60.0 | GO:0032432 | actin filament bundle(GO:0032432) |
0.5 | 2.1 | GO:0045273 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.5 | 1.5 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.5 | 6.7 | GO:0071437 | invadopodium(GO:0071437) |
0.5 | 2.0 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.5 | 29.9 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.5 | 1.5 | GO:1990423 | RZZ complex(GO:1990423) |
0.5 | 88.3 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.5 | 10.6 | GO:0044453 | nuclear membrane part(GO:0044453) |
0.5 | 2.9 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.5 | 89.8 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.5 | 29.8 | GO:0005903 | brush border(GO:0005903) |
0.5 | 194.7 | GO:0005925 | focal adhesion(GO:0005925) |
0.5 | 5.6 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.5 | 3.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.5 | 20.8 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.5 | 6.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.4 | 1.3 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.4 | 2.2 | GO:0030690 | Noc1p-Noc2p complex(GO:0030690) |
0.4 | 2.6 | GO:0005883 | neurofilament(GO:0005883) |
0.4 | 1.3 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
0.4 | 1.3 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
0.4 | 2.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.4 | 6.8 | GO:0044216 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.4 | 5.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.4 | 3.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.4 | 15.5 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.4 | 2.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.4 | 4.2 | GO:0097542 | ciliary tip(GO:0097542) |
0.4 | 9.1 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.4 | 4.9 | GO:0001940 | male pronucleus(GO:0001940) |
0.4 | 0.8 | GO:0048179 | activin receptor complex(GO:0048179) |
0.4 | 61.3 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.4 | 1196.1 | GO:0070062 | extracellular exosome(GO:0070062) |
0.4 | 2.0 | GO:0000938 | GARP complex(GO:0000938) |
0.4 | 6.6 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.4 | 2.7 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.4 | 0.4 | GO:0097427 | microtubule bundle(GO:0097427) |
0.4 | 1.5 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
0.4 | 2.6 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.4 | 1.4 | GO:1990635 | proximal dendrite(GO:1990635) |
0.3 | 3.4 | GO:0008278 | cohesin complex(GO:0008278) |
0.3 | 6.3 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.3 | 409.2 | GO:0005615 | extracellular space(GO:0005615) |
0.3 | 1.0 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.3 | 10.1 | GO:0005882 | intermediate filament(GO:0005882) |
0.3 | 1.6 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.3 | 0.9 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.3 | 1.2 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.3 | 2.9 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.3 | 1.4 | GO:0044307 | dendritic branch(GO:0044307) |
0.3 | 2.8 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.3 | 1.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.3 | 3.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 1.3 | GO:0000799 | nuclear condensin complex(GO:0000799) |
0.2 | 0.7 | GO:0000811 | GINS complex(GO:0000811) |
0.2 | 1.0 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.2 | 0.7 | GO:0032997 | Fc receptor complex(GO:0032997) Fc-epsilon receptor I complex(GO:0032998) |
0.2 | 3.9 | GO:0036038 | MKS complex(GO:0036038) |
0.2 | 0.9 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 1.3 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.2 | 0.6 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.2 | 1.9 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.2 | 1.9 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.2 | 3.3 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 1.4 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.2 | 3.5 | GO:0061702 | inflammasome complex(GO:0061702) |
0.2 | 0.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.2 | 29.5 | GO:0001650 | fibrillar center(GO:0001650) |
0.2 | 0.6 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.2 | 0.7 | GO:0017177 | glucosidase II complex(GO:0017177) |
0.2 | 1.6 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.2 | 0.9 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.2 | 4.1 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.2 | 0.7 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.2 | 0.5 | GO:0070985 | TFIIK complex(GO:0070985) |
0.2 | 5.0 | GO:0010008 | endosome membrane(GO:0010008) |
0.2 | 3.9 | GO:0048475 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.1 | 4.8 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 3.5 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.7 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
0.1 | 0.6 | GO:0008623 | CHRAC(GO:0008623) |
0.1 | 1.7 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 1.1 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
0.1 | 3.4 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 0.1 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
0.1 | 0.1 | GO:0043291 | RAVE complex(GO:0043291) |
0.1 | 0.4 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.1 | 0.1 | GO:0034455 | t-UTP complex(GO:0034455) |
0.1 | 1.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 1.7 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.9 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.6 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.5 | GO:0031251 | PAN complex(GO:0031251) |
0.1 | 0.9 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 0.2 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.1 | 0.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.3 | GO:0019814 | immunoglobulin complex(GO:0019814) |
0.1 | 0.9 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 7.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.7 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.4 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 0.3 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 8.1 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 0.8 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 11.1 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 0.2 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.1 | 0.7 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 4.1 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 0.6 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.1 | 0.6 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 0.8 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 0.2 | GO:0097132 | cyclin D2-CDK6 complex(GO:0097132) |
0.1 | 1.3 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 0.6 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 297.5 | GO:0016021 | integral component of membrane(GO:0016021) |
0.1 | 0.2 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 0.2 | GO:0032545 | CURI complex(GO:0032545) UTP-C complex(GO:0034456) |
0.0 | 0.3 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.0 | 0.4 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.0 | 0.6 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 3.0 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.4 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.2 | GO:0098536 | deuterosome(GO:0098536) |
0.0 | 0.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.2 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.0 | 0.5 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.2 | GO:0001739 | sex chromatin(GO:0001739) |
0.0 | 0.0 | GO:0005668 | RNA polymerase transcription factor SL1 complex(GO:0005668) |
0.0 | 0.1 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 0.1 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.6 | 40.8 | GO:1902121 | lithocholic acid binding(GO:1902121) |
12.2 | 48.7 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
10.9 | 43.4 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
10.1 | 70.9 | GO:1990254 | keratin filament binding(GO:1990254) |
9.7 | 48.6 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
9.7 | 29.0 | GO:0050785 | advanced glycation end-product receptor activity(GO:0050785) |
8.9 | 71.4 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
8.7 | 138.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
8.6 | 42.9 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
8.3 | 24.8 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
7.6 | 22.8 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
7.4 | 88.7 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
7.4 | 29.5 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
7.4 | 22.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
7.2 | 50.7 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
6.8 | 27.4 | GO:0008147 | structural constituent of bone(GO:0008147) |
6.8 | 20.4 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
6.7 | 26.9 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
6.7 | 20.0 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
6.5 | 84.1 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
5.8 | 23.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
5.7 | 17.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
5.6 | 28.1 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
5.6 | 16.8 | GO:0070540 | stearic acid binding(GO:0070540) |
5.4 | 32.6 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
5.3 | 15.8 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
5.2 | 36.7 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
5.1 | 20.5 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
5.1 | 117.5 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
5.1 | 76.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
5.1 | 60.9 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
5.0 | 50.4 | GO:0038132 | neuregulin binding(GO:0038132) |
4.9 | 34.6 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
4.8 | 14.4 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
4.7 | 18.7 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
4.6 | 63.8 | GO:0005243 | gap junction channel activity(GO:0005243) |
4.5 | 13.6 | GO:0031768 | ghrelin receptor binding(GO:0031768) |
4.5 | 98.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
4.5 | 44.6 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
4.4 | 26.3 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
4.4 | 13.1 | GO:0004560 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
4.2 | 54.8 | GO:0071253 | connexin binding(GO:0071253) |
4.1 | 53.9 | GO:0070700 | BMP receptor binding(GO:0070700) |
4.1 | 36.7 | GO:0042285 | xylosyltransferase activity(GO:0042285) |
4.1 | 97.9 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
4.0 | 12.0 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
4.0 | 11.9 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
3.9 | 11.8 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
3.9 | 23.6 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
3.8 | 15.2 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
3.8 | 15.0 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
3.7 | 11.1 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
3.7 | 14.6 | GO:0043682 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
3.6 | 25.4 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
3.5 | 24.6 | GO:0030614 | oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
3.4 | 24.1 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
3.4 | 10.2 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
3.3 | 83.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
3.3 | 13.2 | GO:0047874 | dolichyldiphosphatase activity(GO:0047874) |
3.2 | 103.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
3.2 | 41.9 | GO:0019966 | interleukin-1 binding(GO:0019966) |
3.1 | 12.5 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
3.1 | 12.4 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
3.1 | 37.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
3.1 | 9.3 | GO:0052597 | diamine oxidase activity(GO:0052597) histamine oxidase activity(GO:0052598) methylputrescine oxidase activity(GO:0052599) propane-1,3-diamine oxidase activity(GO:0052600) |
3.0 | 9.1 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
3.0 | 9.1 | GO:0003999 | adenine binding(GO:0002055) adenine phosphoribosyltransferase activity(GO:0003999) |
3.0 | 35.8 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
3.0 | 11.9 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
2.9 | 11.8 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
2.9 | 8.8 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
2.9 | 31.5 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
2.9 | 14.3 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
2.8 | 11.3 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
2.8 | 2.8 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
2.8 | 13.8 | GO:0047635 | L-alanine:2-oxoglutarate aminotransferase activity(GO:0004021) alanine-oxo-acid transaminase activity(GO:0047635) |
2.7 | 13.6 | GO:0030151 | molybdenum ion binding(GO:0030151) |
2.7 | 10.8 | GO:0070976 | TIR domain binding(GO:0070976) |
2.7 | 10.7 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
2.6 | 76.4 | GO:0031005 | filamin binding(GO:0031005) |
2.6 | 13.2 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
2.6 | 2.6 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
2.6 | 10.4 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
2.5 | 15.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
2.5 | 27.4 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
2.5 | 29.9 | GO:0070097 | delta-catenin binding(GO:0070097) |
2.5 | 10.0 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
2.5 | 2.5 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
2.4 | 16.9 | GO:0050294 | alcohol sulfotransferase activity(GO:0004027) steroid sulfotransferase activity(GO:0050294) |
2.4 | 7.2 | GO:0004350 | glutamate 5-kinase activity(GO:0004349) glutamate-5-semialdehyde dehydrogenase activity(GO:0004350) delta1-pyrroline-5-carboxylate synthetase activity(GO:0017084) amino acid kinase activity(GO:0019202) |
2.4 | 9.5 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
2.3 | 7.0 | GO:0008775 | acetate CoA-transferase activity(GO:0008775) |
2.3 | 9.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
2.3 | 40.9 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
2.3 | 13.5 | GO:0042289 | MHC class II protein binding(GO:0042289) |
2.3 | 2.3 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
2.2 | 125.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
2.2 | 11.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
2.2 | 6.6 | GO:0098918 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
2.2 | 6.5 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
2.2 | 6.5 | GO:0001565 | phorbol ester receptor activity(GO:0001565) non-kinase phorbol ester receptor activity(GO:0001566) |
2.1 | 36.4 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
2.1 | 8.5 | GO:0045159 | myosin II binding(GO:0045159) |
2.1 | 6.4 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
2.1 | 6.3 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
2.1 | 8.2 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
2.1 | 14.4 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
2.0 | 6.1 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
2.0 | 8.1 | GO:0050347 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
2.0 | 40.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
2.0 | 20.1 | GO:1901612 | cardiolipin binding(GO:1901612) |
2.0 | 7.9 | GO:0003680 | AT DNA binding(GO:0003680) |
2.0 | 13.7 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
2.0 | 31.2 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
1.9 | 17.3 | GO:0045545 | syndecan binding(GO:0045545) |
1.9 | 19.1 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
1.9 | 7.5 | GO:0036468 | aromatic-L-amino-acid decarboxylase activity(GO:0004058) L-dopa decarboxylase activity(GO:0036468) |
1.9 | 9.4 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
1.8 | 7.4 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.8 | 12.8 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
1.8 | 9.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
1.8 | 3.6 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
1.7 | 10.5 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
1.7 | 6.9 | GO:0051435 | BH4 domain binding(GO:0051435) |
1.7 | 20.4 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
1.7 | 51.0 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
1.7 | 10.1 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
1.7 | 6.7 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
1.7 | 1.7 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
1.7 | 8.3 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
1.7 | 28.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
1.6 | 4.9 | GO:0036461 | AP-3 adaptor complex binding(GO:0035651) BLOC-2 complex binding(GO:0036461) |
1.6 | 8.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
1.6 | 25.8 | GO:0050544 | arachidonic acid binding(GO:0050544) |
1.6 | 11.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
1.6 | 11.2 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
1.6 | 16.0 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
1.6 | 28.5 | GO:0019841 | retinol binding(GO:0019841) |
1.6 | 23.6 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
1.6 | 9.4 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
1.6 | 4.7 | GO:0050479 | glyceryl-ether monooxygenase activity(GO:0050479) |
1.6 | 4.7 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
1.5 | 7.6 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
1.5 | 243.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
1.5 | 22.7 | GO:0051861 | glycolipid binding(GO:0051861) |
1.5 | 10.5 | GO:0042834 | peptidoglycan binding(GO:0042834) |
1.5 | 25.4 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
1.5 | 4.5 | GO:0008124 | 4-alpha-hydroxytetrahydrobiopterin dehydratase activity(GO:0008124) |
1.5 | 10.2 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
1.4 | 82.8 | GO:0042805 | actinin binding(GO:0042805) |
1.4 | 15.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
1.4 | 1.4 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
1.4 | 5.7 | GO:0004337 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
1.4 | 9.8 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
1.4 | 27.7 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
1.4 | 2.8 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
1.4 | 56.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
1.4 | 4.1 | GO:0052692 | raffinose alpha-galactosidase activity(GO:0052692) |
1.4 | 8.1 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
1.4 | 9.5 | GO:0034056 | estrogen response element binding(GO:0034056) |
1.3 | 1.3 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
1.3 | 5.4 | GO:0016708 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
1.3 | 2.7 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
1.3 | 2.7 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
1.3 | 2.6 | GO:0048030 | disaccharide binding(GO:0048030) |
1.3 | 18.3 | GO:0019215 | intermediate filament binding(GO:0019215) |
1.3 | 9.1 | GO:0051425 | PTB domain binding(GO:0051425) |
1.3 | 6.5 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
1.3 | 6.5 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
1.3 | 18.1 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
1.3 | 10.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
1.3 | 1.3 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
1.3 | 35.3 | GO:0031489 | myosin V binding(GO:0031489) |
1.2 | 22.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
1.2 | 6.2 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
1.2 | 34.8 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
1.2 | 16.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
1.2 | 19.7 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
1.2 | 25.9 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
1.2 | 8.5 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
1.2 | 15.8 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.2 | 3.6 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
1.2 | 2.4 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
1.2 | 10.7 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
1.2 | 41.6 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
1.2 | 4.7 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
1.2 | 60.2 | GO:0042379 | chemokine receptor binding(GO:0042379) |
1.2 | 7.0 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
1.2 | 8.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
1.2 | 4.6 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
1.1 | 9.1 | GO:0017040 | ceramidase activity(GO:0017040) |
1.1 | 4.6 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
1.1 | 10.2 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
1.1 | 1.1 | GO:0005110 | frizzled-2 binding(GO:0005110) |
1.1 | 33.9 | GO:0001968 | fibronectin binding(GO:0001968) |
1.1 | 3.4 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
1.1 | 83.1 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
1.1 | 17.9 | GO:0038191 | neuropilin binding(GO:0038191) |
1.1 | 6.7 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
1.1 | 7.8 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
1.1 | 10.0 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
1.1 | 3.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
1.1 | 8.8 | GO:0004046 | aminoacylase activity(GO:0004046) |
1.1 | 28.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
1.1 | 4.3 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
1.1 | 6.5 | GO:0008142 | oxysterol binding(GO:0008142) |
1.1 | 136.4 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
1.1 | 3.2 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
1.1 | 36.4 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
1.1 | 2.1 | GO:0031013 | troponin I binding(GO:0031013) |
1.1 | 3.2 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
1.1 | 12.7 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
1.0 | 30.2 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
1.0 | 4.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
1.0 | 36.9 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
1.0 | 31.4 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
1.0 | 7.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.0 | 3.0 | GO:0030116 | glial cell-derived neurotrophic factor receptor binding(GO:0030116) |
1.0 | 40.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
1.0 | 5.0 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
1.0 | 5.0 | GO:0055100 | adiponectin binding(GO:0055100) adipokinetic hormone receptor activity(GO:0097003) |
1.0 | 6.0 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
1.0 | 4.0 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
1.0 | 5.9 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
1.0 | 5.9 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
1.0 | 30.2 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
1.0 | 24.3 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
1.0 | 6.8 | GO:0001601 | peptide YY receptor activity(GO:0001601) pancreatic polypeptide receptor activity(GO:0001602) |
1.0 | 3.9 | GO:0042008 | interleukin-18 receptor activity(GO:0042008) |
1.0 | 22.9 | GO:0043274 | phospholipase binding(GO:0043274) |
1.0 | 20.0 | GO:0045295 | gamma-catenin binding(GO:0045295) |
1.0 | 5.7 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.9 | 4.7 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
0.9 | 9.4 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.9 | 6.6 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.9 | 2.8 | GO:0004615 | phosphomannomutase activity(GO:0004615) |
0.9 | 10.2 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.9 | 0.9 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.9 | 2.8 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
0.9 | 10.1 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.9 | 4.5 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.9 | 7.2 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.9 | 18.9 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.9 | 6.3 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.9 | 2.7 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
0.9 | 8.7 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.9 | 4.3 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.9 | 179.6 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.9 | 7.7 | GO:0016160 | amylase activity(GO:0016160) |
0.9 | 2.6 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.8 | 6.8 | GO:0004579 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.8 | 18.6 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.8 | 5.0 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.8 | 11.7 | GO:0031996 | thioesterase binding(GO:0031996) |
0.8 | 17.5 | GO:0070513 | death domain binding(GO:0070513) |
0.8 | 4.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.8 | 12.4 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.8 | 7.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.8 | 4.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.8 | 3.3 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.8 | 3.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.8 | 12.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.8 | 3.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.8 | 2.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.8 | 35.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.8 | 3.1 | GO:0043532 | angiostatin binding(GO:0043532) |
0.8 | 1.5 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.8 | 5.3 | GO:0036122 | BMP binding(GO:0036122) |
0.8 | 46.5 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.8 | 6.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.8 | 3.8 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.7 | 3.7 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.7 | 9.6 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.7 | 11.8 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.7 | 3.7 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.7 | 13.3 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.7 | 10.3 | GO:0043495 | protein anchor(GO:0043495) |
0.7 | 3.7 | GO:0005499 | vitamin D binding(GO:0005499) |
0.7 | 35.3 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.7 | 4.3 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.7 | 2.8 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.7 | 6.3 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.7 | 4.9 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.7 | 22.2 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.7 | 6.9 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.7 | 29.9 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.7 | 2.7 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.7 | 18.8 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.7 | 5.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.7 | 3.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.7 | 7.9 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.7 | 5.9 | GO:0004568 | chitinase activity(GO:0004568) |
0.6 | 5.1 | GO:0005124 | scavenger receptor binding(GO:0005124) |
0.6 | 3.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.6 | 7.0 | GO:0031419 | cobalamin binding(GO:0031419) |
0.6 | 22.6 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.6 | 1.9 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.6 | 5.0 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.6 | 385.6 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.6 | 1.8 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.6 | 1.2 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.6 | 3.6 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.6 | 8.5 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.6 | 7.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.6 | 21.5 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.6 | 1.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.6 | 13.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.6 | 4.6 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.6 | 1.1 | GO:1901375 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
0.6 | 15.5 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.6 | 9.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.6 | 1.1 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.6 | 2.3 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.6 | 12.6 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.6 | 1.1 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.6 | 1.7 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
0.6 | 1.7 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.6 | 5.6 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.6 | 1.1 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.6 | 5.0 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.6 | 3.9 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.6 | 1.7 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
0.5 | 2.2 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.5 | 6.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.5 | 1.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.5 | 4.2 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.5 | 5.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.5 | 2.6 | GO:0043515 | kinetochore binding(GO:0043515) |
0.5 | 2.1 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.5 | 24.3 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.5 | 3.6 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.5 | 6.7 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.5 | 2.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.5 | 2.0 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.5 | 3.0 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.5 | 6.1 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.5 | 13.1 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.5 | 1.5 | GO:0004454 | ketohexokinase activity(GO:0004454) |
0.5 | 2.0 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
0.5 | 4.0 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.5 | 1.0 | GO:0001607 | neuromedin U receptor activity(GO:0001607) |
0.5 | 8.7 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.5 | 3.4 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.5 | 6.6 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.5 | 14.5 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.5 | 7.9 | GO:0005123 | death receptor binding(GO:0005123) |
0.5 | 9.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.5 | 4.2 | GO:0050692 | DBD domain binding(GO:0050692) |
0.5 | 73.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.5 | 3.7 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.5 | 1.4 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.5 | 1.4 | GO:0016662 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitric oxide binding(GO:0070026) |
0.5 | 1.4 | GO:0008456 | alpha-galactosidase activity(GO:0004557) alpha-N-acetylgalactosaminidase activity(GO:0008456) |
0.5 | 2.3 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.4 | 1.3 | GO:0031755 | endothelial differentiation G-protein coupled receptor binding(GO:0031753) Edg-2 lysophosphatidic acid receptor binding(GO:0031755) |
0.4 | 1.3 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.4 | 2.6 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.4 | 2.6 | GO:0016936 | galactoside binding(GO:0016936) |
0.4 | 1.3 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.4 | 10.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.4 | 12.4 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.4 | 0.9 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.4 | 5.1 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.4 | 1.7 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.4 | 1.3 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.4 | 1.3 | GO:0004686 | elongation factor-2 kinase activity(GO:0004686) |
0.4 | 1.3 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.4 | 3.3 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.4 | 7.1 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.4 | 0.8 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.4 | 5.3 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.4 | 4.8 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.4 | 10.5 | GO:0003823 | antigen binding(GO:0003823) |
0.4 | 2.8 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.4 | 1.6 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.4 | 2.0 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.4 | 4.0 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.4 | 1.2 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.4 | 0.8 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.4 | 1.6 | GO:0048185 | activin binding(GO:0048185) |
0.4 | 21.4 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.4 | 3.9 | GO:0015925 | galactosidase activity(GO:0015925) |
0.4 | 44.2 | GO:0005496 | steroid binding(GO:0005496) |
0.4 | 1.9 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.4 | 2.3 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.4 | 1.5 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.4 | 1.9 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.4 | 6.7 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.4 | 3.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.4 | 0.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.4 | 1.1 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
0.4 | 48.2 | GO:0008201 | heparin binding(GO:0008201) |
0.4 | 3.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.4 | 1.8 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.4 | 1.4 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.4 | 1.1 | GO:0047945 | L-phenylalanine:pyruvate aminotransferase activity(GO:0047312) glutamine-phenylpyruvate transaminase activity(GO:0047316) L-glutamine:pyruvate aminotransferase activity(GO:0047945) |
0.4 | 5.3 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.3 | 6.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.3 | 2.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.3 | 2.1 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.3 | 3.4 | GO:0015288 | porin activity(GO:0015288) |
0.3 | 75.7 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.3 | 1.3 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.3 | 1.0 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.3 | 3.9 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.3 | 2.6 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.3 | 3.8 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.3 | 3.5 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.3 | 2.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.3 | 54.6 | GO:0005125 | cytokine activity(GO:0005125) |
0.3 | 1.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.3 | 1.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.3 | 15.1 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.3 | 1.5 | GO:0045340 | mercury ion binding(GO:0045340) |
0.3 | 3.4 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.3 | 1.8 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.3 | 2.9 | GO:0051400 | BH domain binding(GO:0051400) |
0.3 | 2.1 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.3 | 4.1 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.3 | 1.7 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.3 | 0.9 | GO:0090555 | phosphatidylethanolamine-translocating ATPase activity(GO:0090555) |
0.3 | 0.6 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.3 | 0.3 | GO:0001851 | complement component C3b binding(GO:0001851) |
0.3 | 0.6 | GO:0035539 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
0.3 | 1.1 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.3 | 0.8 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.3 | 0.5 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
0.3 | 77.8 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.3 | 1.3 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.3 | 10.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.3 | 0.5 | GO:0043559 | insulin binding(GO:0043559) |
0.3 | 1.0 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.3 | 0.3 | GO:0004823 | leucine-tRNA ligase activity(GO:0004823) |
0.2 | 1.0 | GO:0072354 | histone kinase activity (H3-T3 specific)(GO:0072354) |
0.2 | 1.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.2 | 0.7 | GO:0070279 | vitamin B6 binding(GO:0070279) |
0.2 | 2.7 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.2 | 1.0 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.2 | 1.0 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.2 | 1.9 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.2 | 1.4 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.2 | 0.9 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.2 | 2.1 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.2 | 3.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 1.8 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.2 | 0.7 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
0.2 | 8.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 3.8 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.2 | 2.7 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.2 | 1.1 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.2 | 153.2 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.2 | 2.8 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 7.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 3.5 | GO:0031386 | protein tag(GO:0031386) |
0.2 | 7.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 1.3 | GO:0030546 | receptor activator activity(GO:0030546) |
0.2 | 2.8 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.2 | 1.1 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.2 | 0.6 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
0.2 | 3.3 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 4.7 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.2 | 13.5 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.2 | 0.4 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.2 | 1.6 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.2 | 1.4 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.2 | 0.6 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.2 | 22.2 | GO:0005179 | hormone activity(GO:0005179) |
0.2 | 1.6 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.2 | 1.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.2 | 4.3 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.2 | 1.8 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.2 | 1.3 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.2 | 3.3 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.2 | 1.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 0.9 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
0.2 | 0.7 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.2 | 0.5 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.2 | 2.5 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.2 | 0.7 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.2 | 0.7 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.2 | 1.4 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.2 | 6.6 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.2 | 96.6 | GO:0005198 | structural molecule activity(GO:0005198) |
0.2 | 0.5 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) calcium-induced calcium release activity(GO:0048763) |
0.2 | 1.5 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.2 | 0.3 | GO:0035375 | zymogen binding(GO:0035375) |
0.2 | 1.1 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.1 | 0.3 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.1 | 0.9 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 1.0 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.6 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 1.3 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 1.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 8.9 | GO:0008083 | growth factor activity(GO:0008083) |
0.1 | 1.0 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.7 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.1 | 0.5 | GO:0032357 | oxidized purine DNA binding(GO:0032357) |
0.1 | 0.3 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.1 | 0.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 19.3 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.7 | GO:0070883 | siRNA binding(GO:0035197) pre-miRNA binding(GO:0070883) |
0.1 | 1.7 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 3.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.5 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 0.6 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.6 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.1 | 2.6 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 1.5 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.1 | 2.0 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 0.8 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.6 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.6 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 2.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.5 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.4 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 1.0 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 0.5 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 1.1 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 6.0 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.7 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.1 | 0.6 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 0.6 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 0.8 | GO:0043236 | laminin binding(GO:0043236) |
0.1 | 0.2 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.1 | 0.5 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 1.0 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
0.1 | 1.1 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 1.0 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.5 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.1 | 3.1 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.2 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.1 | 1.9 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.1 | 5.7 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 1.2 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 0.6 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.1 | 1.5 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 0.4 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 18.4 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 1.6 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 2.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 1.0 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.5 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 0.9 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.1 | 0.3 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.6 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 2.2 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.1 | 0.3 | GO:0099528 | G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.1 | 0.7 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 0.3 | GO:0030629 | U6 snRNA 3'-end binding(GO:0030629) |
0.1 | 2.8 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.1 | 0.1 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.1 | 0.4 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 0.3 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.1 | 0.2 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.1 | 0.2 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.1 | 0.2 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 0.2 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.1 | 0.5 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.6 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.6 | GO:0051870 | methotrexate binding(GO:0051870) |
0.1 | 1.7 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 1.3 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.1 | 3.1 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 0.2 | GO:0035717 | chemokine (C-C motif) ligand 7 binding(GO:0035717) |
0.1 | 0.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.3 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.6 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 1.4 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.0 | 0.9 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.2 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.7 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.3 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.0 | 0.1 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
0.0 | 0.1 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
0.0 | 0.8 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.1 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.0 | 0.1 | GO:0004756 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
0.0 | 0.2 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.0 | 16.0 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.2 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.0 | 0.1 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.0 | 0.1 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.0 | 0.9 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.1 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
0.0 | 0.4 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.1 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.0 | 0.1 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.0 | 0.4 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.0 | 0.2 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.0 | 0.1 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.1 | GO:0008396 | oxysterol 7-alpha-hydroxylase activity(GO:0008396) |
0.0 | 0.1 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.0 | 0.2 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.2 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.0 | 0.0 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.2 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.2 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 1.3 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.5 | 93.6 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
5.1 | 86.9 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
2.8 | 83.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
2.7 | 163.4 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
2.5 | 117.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
2.5 | 79.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
1.8 | 18.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
1.7 | 1.7 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
1.6 | 14.7 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
1.5 | 89.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
1.5 | 146.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
1.3 | 64.3 | PID RHOA PATHWAY | RhoA signaling pathway |
1.2 | 54.7 | PID BMP PATHWAY | BMP receptor signaling |
1.2 | 1.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
1.2 | 23.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
1.2 | 90.0 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
1.1 | 39.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.9 | 8.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.9 | 6.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.9 | 3.4 | PID ALK2 PATHWAY | ALK2 signaling events |
0.9 | 15.4 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.8 | 13.5 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.8 | 24.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.8 | 4.5 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.8 | 8.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.7 | 16.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.7 | 9.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.7 | 28.0 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.7 | 20.5 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.7 | 45.5 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.7 | 27.8 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.6 | 11.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.6 | 23.0 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.6 | 38.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.6 | 119.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.6 | 60.3 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.5 | 16.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.5 | 11.4 | PID ARF 3PATHWAY | Arf1 pathway |
0.5 | 2.5 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.5 | 24.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.5 | 3.7 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.4 | 9.4 | PID ARF6 PATHWAY | Arf6 signaling events |
0.4 | 23.6 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.4 | 10.2 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.4 | 23.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.4 | 33.2 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.4 | 10.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.4 | 8.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.3 | 9.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.3 | 7.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.3 | 12.1 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.3 | 3.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.3 | 6.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 11.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.3 | 1.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.3 | 10.2 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.3 | 5.8 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.3 | 1.6 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.3 | 8.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.3 | 5.8 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.3 | 10.9 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 4.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 72.1 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.2 | 10.7 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 22.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.2 | 14.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 16.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 3.7 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 5.6 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.2 | 0.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 5.0 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 5.2 | PID E2F PATHWAY | E2F transcription factor network |
0.2 | 1.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.2 | 5.3 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.2 | 1.4 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 4.7 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 5.5 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 12.2 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 0.7 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 2.0 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 0.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 2.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 0.7 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.1 | 0.8 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 3.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.7 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 0.5 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 1.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 1.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.7 | 301.5 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
9.4 | 140.6 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
8.3 | 340.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
5.0 | 120.8 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
2.9 | 61.8 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
2.6 | 60.6 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
2.5 | 58.1 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
2.4 | 51.9 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
2.3 | 42.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
2.2 | 21.9 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
2.0 | 10.1 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
2.0 | 98.4 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
1.9 | 76.3 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
1.9 | 15.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
1.8 | 7.2 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
1.8 | 47.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
1.7 | 31.1 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
1.7 | 69.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
1.6 | 74.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
1.6 | 108.5 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
1.5 | 40.2 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
1.5 | 89.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
1.5 | 101.5 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
1.4 | 19.7 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
1.4 | 114.4 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
1.3 | 69.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
1.3 | 40.9 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
1.3 | 57.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
1.2 | 35.7 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
1.1 | 35.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
1.1 | 8.9 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.1 | 13.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
1.1 | 11.8 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
1.1 | 16.1 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
1.1 | 95.0 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
1.1 | 34.8 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
1.0 | 5.1 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
1.0 | 21.7 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
1.0 | 21.2 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.9 | 21.4 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.9 | 11.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.9 | 13.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.8 | 10.1 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.8 | 7.5 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.8 | 33.4 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.8 | 6.7 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.8 | 2.4 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.8 | 9.7 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.8 | 6.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.7 | 31.7 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.7 | 23.0 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.6 | 9.6 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.6 | 20.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.6 | 5.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.6 | 13.0 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.6 | 1.2 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.6 | 32.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.6 | 9.4 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.6 | 41.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.6 | 3.4 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.5 | 20.8 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.5 | 10.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.5 | 7.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.5 | 3.8 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.5 | 45.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.5 | 4.7 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.4 | 10.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.4 | 5.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.4 | 13.8 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.4 | 10.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.4 | 3.4 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.4 | 7.1 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.4 | 15.7 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.4 | 7.4 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.4 | 7.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.4 | 9.5 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.4 | 12.9 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.4 | 5.5 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.4 | 4.6 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.4 | 0.8 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.4 | 8.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.4 | 51.0 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.3 | 13.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.3 | 22.4 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.3 | 6.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.3 | 4.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.3 | 46.5 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.3 | 40.7 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.3 | 6.8 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.3 | 1.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.3 | 2.6 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.3 | 2.9 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.3 | 3.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.3 | 3.8 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.3 | 0.6 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.3 | 8.1 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.3 | 1.2 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.3 | 0.6 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.3 | 36.6 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.3 | 10.7 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.3 | 3.1 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.3 | 5.3 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.3 | 2.5 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.3 | 2.0 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.2 | 2.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.2 | 11.0 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.2 | 6.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.2 | 11.9 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.2 | 6.8 | REACTOME KINESINS | Genes involved in Kinesins |
0.2 | 2.6 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.2 | 4.0 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 6.8 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.2 | 4.6 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 1.5 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.2 | 2.5 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 0.3 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 4.5 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.2 | 2.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 1.6 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 2.6 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.1 | 1.2 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
0.1 | 2.4 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 1.4 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 0.1 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 0.6 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 1.0 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 8.7 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 1.8 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.7 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 2.6 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.1 | 1.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 0.9 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 1.1 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 1.1 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.7 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.1 | 1.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 5.6 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 2.6 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 0.3 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.1 | 1.3 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 2.8 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.1 | 1.1 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 0.4 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.1 | 1.2 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.1 | 2.5 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.2 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.5 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 1.2 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 0.4 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
0.0 | 0.6 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 1.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.4 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.2 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.2 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |